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Abstract
Propensity score (PS) weighting methods are often used in non-randomized studies to
adjust for confounding and assess treatment effects. The most popular among them,
the inverse probability weighting (IPW), assigns weights that are proportional to the
inverse of the conditional probability of a specific treatment assignment, given observed
covariates. A key requirement for IPW estimation is the positivity assumption, i.e.,
the PS must be bounded away from 0 and 1. In practice, violations of the positivity
assumption often manifest by the presence of limited overlap in the PS distributions
between treatment groups. When these practical violations occur, a small number of
highly influential IPW weights may lead to unstable IPW estimators, with biased esti-
mates and large variances. To mitigate these issues, a number of alternative methods
have been proposed, including IPW trimming, overlap weights (OW), matching weights
(MW), and entropy weights (EW). Because OW, MW, and EW target the population
for whom there is equipoise (and with adequate overlap) and their estimands depend on
the true PS, a common criticism is that these estimators may be more sensitive to mis-
specifications of the PS model. In this paper, we conduct extensive simulation studies to
compare the performances of IPW and IPW trimming against those of OW, MW, and
EW under limited overlap and misspecified propensity score models. Across the wide
range of scenarios we considered, OW, MW, and EW consistently outperform IPW in
terms of bias, root mean squared error, and coverage probability.
1 Introduction
In non-randomized studies, propensity score (PS) weighting methods are often used to
adjust for potential confounding when estimating treatment effects. The PS is the prob-
ability of receiving a treatment, conditional on the observed covariates. It can be used
as a balancing score to compare treatment groups, i.e., given the PS, the distributions
of observed covariates between treatment groups are similar [1]. Therefore, with the use
of PSs, it is feasible to obtain, under certain conditions, results that mimic some aspects
of a randomized trial study design and allows an appropriate estimation of the causal
effects [2, 3].
In this paper, we are concerned with the use of propensity score weights to estimate
the average treatment effect (ATE). The traditional inverse probability weighting (IPW)
assigns weights to each observation from a study sample that are determined by the in-
verse probability of receiving the treatment that was actually received. After weighting,
both treatment groups will better reflect the distribution of patient characteristics in
the population from which the sample was drawn [4, 5]. Under the assumptions of
stable unit treatment value, conditional independence, and positivity (see Section 2 for
definitions)—along with a correctly specified PS model—IPW leads to consistent esti-
mator of the ATE [6]. In practice, two important diagnostic evaluations are conducted
when using IPW. One, to evaluate the covariate balance (before and after weighting)
and ensure that weighting leads to comparable treatment groups, with respect to the
measured covariates. The other, to assess the positivity assumption by looking at the
overlap of the PS distributions between the treatment groups and their common support
[7]. Lack of sufficient overlap can be indicative of violation of the positivity assumption,
which can lead to extremely large IPW weights [8, 9]. Unfortunately, when present, IPW
estimators can be unduly influenced by few observations with extreme weights, leading
to both biased and unstable results [10, 8, 11, 9]. To analyze data, we either truncate
extreme weights by shrinking them to some smaller fixed value(s) (e.g., capping extreme
weights to the 10th and 90th percentiles) [12, 11] or exclude from our analysis subjects
with extreme weights and by restrict the analysis to observations with modest and less
influential weights, potentially introducing bias and reducing efficiency.
To mitigate these issues inherent to IPW estimators, several alternative methods (to
handle or modify PS weights) have been proposed, including trimming IPW weights,
overlap weights (OW), and matching (MW) weights [13, 14, 15, 16, 17, 18, 19]. These
weights are part of a class of balancing weights that target a judiciously chosen subpop-
ulation of interest from which an estimand closely-related to the ATE can be estimated
with better precision [14, 13, 20, 15, 18, 19, 21, 17]. While there are many versions of
IPW trimming [15, 17], Crump et al. [14] have shown that a good cutoff may be approxi-
mated by 0.1 and thus recommend, as rule-of-thumb, to exclude from statistical analysis
observations with PS outside of the interval [0.1, 0.9] for an improved estimation. Both
OW and MW emphasize a subpopulation that exhibits better overlap in the distribution
of the (measured) covariates, similar to the target population of patients for whom there
is clinical equipoise used in randomized clinical trials [20, 18]. These different weighting
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schemes offer substantial advantages compared to IPW, in terms of improved covari-
ate balance, bias, and precision—assuming a correctly specified propensity score model
[22, 13, 14, 23, 20, 18, 17, 15, 19, 21]. However, only IPW and trimming have been
investigated under misspecifications of the propensity score model [10, 8, 11, 7, 9].
In practice, true PSs are unknown in non-randomized studies and must be estimated.
However, while OW and MW perform relatively well in the presence of extreme weights
and under correctly specified PS models, little is known about their performances when
the PS model is misspecified. Because the estimands (i.e., the targets of inference)
of OW and MW depend on the true PS (through their underlying target population),
misspecifications of the PS model are of genuine concern; it appears that estimating
these targets of inference may be tightly dependent on a correct specification of the
PS model. Hence, it has been hypothesized that OW and MW estimators might be
more sensitive to misspecifications of the propensity score model than IPW estimators.
Nevertheless, the PS is a balancing score. As argued by Chakraborty and Moodie,
[24] ”’correct’ specification of the PS model does not require complete knowledge” of
the data generating process behind the treatment allocation. Of primary interest in
most PS methods is whether the PS model includes adequately all the confounding
variables of the treatment-outcome relationship and how well the proposed working
model captures the inherent impact of these covariates on the treatment allocation. To
the best of our knowledge, it is still unclear whether OW and MW estimators are robust
to misspecifications of the PS model.
Moreover, since the selection (or tilting) functions used to derive matching and over-
lap weights are part of a trio of functions commonly used in other fields, we also inves-
tigate the performance of the entropy weights (EW) that are obtained using the cross-
entropy function. These three functions—usually referred to as misclassification error,
Gini index, and Shannon’s cross-entropy—are ubiquitous in classification and regression
tree methods and in information theory [25, 26, 27].
Therefore, in this paper, we investigate whether OW, MW, and EW are better alter-
natives to IPW in the presence of limited PS overlap or misspecifications of the PS model.
We use results from standard M-estimation theory [28, 29] to adjust for uncertainties
in PS estimation and derive in Appendix A empirical sandwich variance estimators for
better precision.
The remaining of this paper is organized as follows. We begin Section 2 with our
notations and a brief review of the class of balancing weights. We also provide a table
that lists the different balancing weight methods, their estimands, and their correspond-
ing weights. Our investigation is motivated by the example of estimating the effect of
maternal smoking on offspring birth weight, in Section 3. Section 4 details simulation
settings and results. In Section 5, we discuss the findings and implications to analysis
based on propensity score weighting.
2
2 Overview of the weighting methods
2.1 Notation and assumptions
Let X denote the vector of measured pre-treatment covariates, Y the observed outcome,
and Z the indicator of treatment options; we use the generic terms ”treatment” (Z = 1)
and ”control” (Z = 0). The data consist of a sample {(Xi, Zi, Yi), i = 1, . . . , N} of
N subjects from the population of interest to which the treatment will eventually be
applied. The propensity score e(X) is the probability of treatment Pr(Z = 1|X),
condition on the covariates X [1].
We consider the potential outcome framework of Rubin [30], where each subject has
two potential outcomes Y (0) and Y (1), one of which would be observed under a given
treatment assignment. To infer causality, we make three untestable assumptions. First,
the stable unit treatment value assumption (SUTVA)[31], i.e., for each subject, the
observed outcome Yi = ZiYi(1) + (1−Zi)Yi(0). Second, we assume the conditional inde-
pendence of the treatment assignment, i.e., the set X is sufficient enough to control for
confounding [1], i.e, E [Y (z) | Z = z,X] = E [Y (z) |X] , z = 0, 1. Finally, a key require-
ment for PS methods is the positivity assumption, i.e., P ({x : ν < e(x) < 1− ν}) = 1,
for some ν > 0 [1]. The positivity assumption states that each subject has a nonzero
probability to receive either treatment. Without positivity, groups can not be made
comparable with the existing data and the treatment effect of interest is not identifiable
[32, 4].
2.2 Practical violations of the positivity assumption
Practical violations of the positivity assumption occur when some subjects almost al-
ways (or almost never) receive treatment, i = 1, . . . , N i.e., when ê(xi) ≈ 0 or 1. Such
violations may arise for several reasons, including data limitations (where subjects with
some specific covariates cannot possibly receive one of the treatment options), small
sample size, and misspecifications of the PS model [8, 33]. When ê(x) ≈ 0 or 1, which
may be the result of a limited overlap in the covariate distributions of the two treatment
groups, estimated IPW weights ŵ(x) can be extreme for some participants. Unfortu-
nately, extreme IPW weights often lead to biased and unstable ATE estimates, with
large variances [34, 7, 35].
Moreover the occurrence of non-positivity sometimes suggests a conceptual problem
with the study design; the sampling scheme includes people for whom the treatment
decision is less ambiguous (or even vividly clear) that it is nearly deterministic. This
is the case, for instance, when some patients have specific counter-indication for one
the drugs under study, when frail and old patients are considered not good candidates
for some invasive open-heart surgery such as a surgical aortic valve replacement [36],
or when some younger, pre-menopausal women with uterine fibroids forgo hysterectomy
and opt for myomectomy, a uterine-sparing treatment option, to keep alive their dream
to bear children [37]. The evidence for making treatment decisions in such patients
is apparently already strong, and thus the need for treatment effect estimation is less
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clear. This motivates the consideration of alternative target populations for whom the
treatment effect may be more relevant and better estimated, with respect to bias and
variance.
2.3 The class of balancing weights
The class of balancing weights includes traditional IPW along with alternatives (weight
trimming, MW, OW and EW) that restrict estimation of the treatment effect to a region
of reasonable positivity, bounded away from 0 and 1 (see Table 1)[13, 14, 34, 8]. The
essence of weighting is to use propensity scores to create a pseudopopulation in which
treatment and control groups are balanced in covariates distributions.
Let f(x) denote the marginal density of covariates X in the population that was sam-
pled (combined over both treatments). Assume f(x) exists, then the density of the target
population can be represented by f(x)h(x), where h(x) is a prespecified tilting function
of x defining the target population. In other words, h(x) serves to re-distribute patient
characteristics from distribution sampled, f(x), to another distribution that is more
clinically relevant or statistically optimal. If f(x) is of primary interest, h(x) = 1. Let
fz(x) = Pr(X = x | Z = z) be the density of X in the z group, then f1(x) ∝ f(x)e(x)
and f0(x) ∝ f(x)(1−e(x)). For a given tilting function h(x), the corresponding weights
for each treatment group wz(x) are defined as follows.
w1(x) ∝ f(x)h(x)
f(x)e(x)
=
h(x)
e(x)
, for z = 1,
w0(x) ∝ f(x)h(x)
f(x)(1− e(x)) =
h(x)
(1− e(x)) , for z = 0. (1)
This class of weights wz(x) are called balancing weights because of their property to
balance the weighted covariates distributions: f1(x)w1(x) = f0(x)w0(x) = f(x)h(x)
[20].
2.3.1 Target estimands
With a function h(x), our goal is to estimate the weighted average treatment effect
[22, 20]
∆h =
E[h(X)(Y (1)− Y (0))]
E(h(X))
(2)
When h(x) is equal to 1, e(x), or 1 − e(x), the estimand ∆h corresponds to the av-
erage treatment effect (ATE), the average treatment effect on the treated (ATT), or
the average treatment effect on the controls (ATC), respectively [22, 17, 20]. Therefore,
different tilting functions h(x) lead to different targets of inference, i.e., different ways
to evaluate causal treatment effects (see Table 1). The ideal target population (and
tilting function) may vary across medical studies due to different clinical context, initial
sampling scheme, or statistical considerations [18, 17]. In addition, when the treatment
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Table 1: Examples of tilting functions, targeted (sub)populations, causal estimands, and
their weights
Target Weights
population h(x) Estimand w1(x) w0(x) Name
overall 1 ATE e(x)−1 (1− e(x))−1 IPW
trimmed Iα(x) OSATE Iα(x)e(x)
−1 Iα(x)(1− e(x))−1 Trimmed IPW
treated e(x) ATT 1 e(x)(1− e(x))−1 IPW for treated
controls 1− e(x) ATC (1− e(x))e(x)−1 1 IPW for controls
equipoise
e(x) (1− e(x)) ATO 1− e(x) e(x) overlap weights
u(x) u(x)e(x)−1 u(x)(1− e(x))−1 matching weights
ξ(x) ξ(x)e(x)−1 ξ(x)(1− e(x))−1 entropy weights
Iα(x) = 1({α ≤ e(x) ≤ 1− α}), where 0 < α < 0.5 and 1(.) is the standard indicator function;
u(x) = min{e(x), 1− e(x)}; ξ(x) = −{e(x) ln(e(x)) + (1− e(x)) ln (1− e(x))}.
OSATE: Optimal sample average treatment effect; [14] ATO: Average treatment effect for the overlap
population [20].
effect is constant, the estimand will be the same for all h. It is only when the treatment
effect is heterogeneous that different tilting functions can lead to different estimands.
Note also that ∆h in equation (2) is defined in term of the true propensity score, not
on the estimated score. In the examples provided in Table 1, h(X) ≡ h(e(X)), i.e., a
function of the true (albeit unknown!) propensity score, except for the tilting function
of ATE estimand via the IPW method. As such, ∆h is well-defined since we assume the
existence of potential outcomes Y (z), z = 0, 1, and of the true propensity score e(X).
It’s identifiability is guaranteed by the SUTVA assumption and the conditional inde-
pendence of treatment assignment assumptions. Now, whether we are able to correctly
estimate such a quantity, based on a data set at hand, is a different issue.
In Figure 1 we compare some of the tilting functions; the functions were scaled
(by multiplying each function by some constant) in a way that they all reach 0.5 as
maximum whenever e(x) = 0.5. Multiplying a tilting function by a constant is not
essential and doesn’t change the nature of the estimand of interest. This figure shows
how different tilting functions re-weight the target population. IPW does not change
the distribution at all. IPW with trimming excludes all patients with PS values beyond
a threshold (e.g., keep only observations with PS inside the [0.1, 0.9]). In contrast, OW,
MW, and EW keep the entire sample size and tilt f(x) towards 0.50 and away from
0 or 1. This circumvents the need to discard observations with extreme weights since
their relative weights and influence dwindle the closer the PS approaches 0 or 1. In
fact, these estimators counter the unduly influence of observations at the tails of the PS
distributions might have exerted on the treatment effect estimation by smoothly down-
weighting them and thus strategically target the subpopulation of subjects for whom
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Figure 1: Tilting functions for IPW and the optimal IPW trimming (left) and for OW,
MW, and EW (right)
there is most clinical equipoise. [17, 18] The difference between OW, MW and EW is in
how sharply the tails are down-weighted (Figure 1).
2.3.2 Estimation
The estimator ∆̂h of the causal target of inference ∆h can be determined as
∆̂h =
N∑
i=1
ZiYiŵi(x)
N∑
i=1
Ziŵi(x)
−
N∑
i=1
(1− Zi)Yiŵi(x)
N∑
i=1
(1− Zi)ŵi(x)
(3)
where ŵ(x) = Zŵ1(x) + (1 − Z)ŵ0(x) are the estimated weights. For non-randomized
studies, the PS is unknown and e(x) usually estimated by logistic regression.
The statistical properties of the estimator ∆̂h can be found in the literature. [22,
23, 17, 20, 18, 21] When h(x) = 1, the above estimator ∆̂h correspond to the modified
Horvitz-Thompson IPW estimator, also known as the Hajek’s estimator. [38] It is more
efficient than the standard Horvitz-Thompson IPW estimator [39, 29, 35] and correspond
to a version of stabilized IPW estimator of Hernan and Robins [40] with weights
Zg(Z)
ei(X)
and
(1− Z)g(Z)
1− ei(X) , if we define
g(Z) =
Z ( N∑
i=1
Ziei(X)
−1
)−1
+ (1− Z)
(
N∑
i=1
(1− Zi)(1− ei(Xi))−1
)−1−1
However, we did not considered the version of stabilized-weight estimator for which
g(Z) = ZP (Z = 1)+(1−Z)P (Z = 0) [4, 40] since we decided to use normalized weights
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for all estimators we compared, for consistency. Nevertheless, we have provided the
sandwich variance estimators of these latter stabilized weights in the Appendix A.2.
In summary, whenever the PS model is correctly specified, but there are extreme
IPW weights, the above alternatives (OW, MW, and EW) are more reliable than the
IPW and even IPW trimming; no exclusion and no reduction in sample size; improved
covariate balance, better precision, and better point estimation [14, 13, 17, 20, 18, 23].
When extreme weights are not present and correspondingly the PS distribution has good
overlap between treatment groups, balancing weights perform similarly. However, little
is known about the behaviors of OW, MW, and EW when the PS model is misspecified.
To fill this gap in our knowledge, we first compare the asymptotic statistical properties of
IPW, OW, MW, and EW. Later, we run simulation studies to evaluate their performance
under PS model misspecification, in finite samples.
2.4 Asymptotic behaviors when the positivity assumption is violated
or the propensity score model is misspecified
The asymptotic behaviors of IPW, OW, MW, and EW estimators can be assessed using
results from the semi-parametric theory (see, for instance, Tsiatis [41]). Given h(x), the
estimator ∆̂h = ∆̂1h − ∆̂0h can be derived via the solutions
(
∆̂1h, ∆̂0h
)
to the estimat-
ing equation
N∑
i=1
(
Zih(X)
e(Xi)
(Yi −∆1h), (1− Zi)h(X)
1− e(Xi) (Yi −∆0h))
)′
= 0, with respect to
(∆1h,∆0h), i.e.,
(
∆̂1h, ∆̂0h
)
=

N∑
i=1
ZiYiŵi(x)
N∑
i=1
Ziŵi(x)
,
N∑
i=1
(1− Zi)Yiŵi(x)
N∑
i=1
(1− Zi)ŵi(x)
 .
Consider, mz(X) = E(Y |Z = z,X) for z = 0, 1 and σ2z(X) = V ar(Y |Z = z,X). As
shown by Hirano et al. [22], the efficient influence function of ∆̂h is given by
EIFh =
h(X)
E [h(X)]
[
ZY
e(X)
− (1− Z)Y
1− e(X) − {Z − e(X)} {m1(X) +m0(X)} −∆h
]
The asymptotic variance of ∆̂h is the variance of its influence function EIFh [41], i.e.,
AV(∆̂h) = E [h(X)]
−2E
[
h(X)2
{
σ21(X)e(X)
−1 + σ20(X)(1− e(X))−1
}]
. (4)
This last equation (4) can be used to show the stark contrast between the asymptotic
variance of the IPW estimator (i.e., h(X) = 1) and those of the OW, MW, and EW
estimators when the propensity scores e(X) are near 0 or 1.
Whenever e(X) ≈ 0 or 1 for some observations, their contributions to the asymptotic
variance AV(∆̂h) of either of the last 3 estimators are negligible, since h(X) ≈ 0 and
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h(X)2
{
σ21(X)e(X)
−1 + σ20(X)(1− e(X))−1
} ≈ 0 in these regions of the PS spectrum.
However, for the IPW estimator, AV(∆̂h) = E
[
σ21(X)e(X)
−1 + σ20(X)(1− e(X))−1
]
can take large values when e(X) ≈ 0 or 1, even if the treatment effect is constant.
Furthermore, when the PS model is misspecified, ê(X) converges to e˜(X) 6= e(X)
and thus yields a biased estimator ∆˜h. The asymptotic bias of ∆˜h is equal to
ABias(∆̂h) =
E
[
e(X)
e˜(X)
h˜(X)m1(X)
]
E
[
e(X)
e˜(X)
h˜(X)
] − E
[
1− e(X)
1− e˜(X) h˜(X)m0(X)
]
E
[
1− e(X)
1− e˜(X) h˜(X)
] −∆h (5)
based on the results from Appendix B.
Therefore, if the treatment is constant, then the difference m1(X)−m0(X) is con-
stant for z = 0, 1 and ABias(∆̂h) ≈ 0. However, when the treatment effect is het-
erogeneous and the PS model is misspecified, i.e., e˜(X) 6= e(X), the impact of such
misspecification in the asymptotic bias of the IPW estimator ∆̂h=1 can be exacerbated
by the presence of observations with e˜(X) ≈ 0 or 1, since its asymptotic bias (5) is
E
[
e(X)
e˜(X)
]−1
E
[
e(X)
e˜(X)
m1(X)
]
− E
[
1− e(X)
1− e˜(X)
]−1
E
[
1− e(X)
1− e˜(X)m0(X)
]
−∆h.
For the OW, MW, or EW estimator,
e(X)h˜(X)
e˜(X)
≈ 0 and 1− e(X)h˜(X)
1− e˜(X) ≈ 0 in (5),
when e˜(X) ≈ 0 or 1, and thus do not contribute much to the asymptotic bias.
Overall, OW, MW, and EW have better asymptotic behaviors compared to IPW
weights. While we expect these behaviors we have uncovered here to carry over in finite
sample size, we run simulation studies, in Section 4, to find out.
3 Motivating example
To set the stage, we consider data from the North Carolina vital statistics recorded
between 1998 and 2002 by the North Carolina State Center Health Services, accessible
through the Odum Institute at the University of North Carolina in Chapel Hill. The
goal is to estimate the effects of maternal smoking on infant birth weights (measured in
grams) from first-time black mothers (N = 157, 988).
Given that maternal smoking is non-randomized propensity scores are used to adjust
for differences in women who smoke and those who do not. The propensity score model,
based on a logistic regression, includes 5 continuous variables (mother’s age, years of
education, duration of gestation, month of first prenatal visit and number of prenatal
visits), as well as 11 binary variables (indicator of baby’s gender; mother’s marital status,
gestational diabetes, hypertension, amniocentesis, ultrasound exam and previous terms
where newborn died, adequate Kessner Index, inadequate Kessner Index, and alcohol
consumption during pregnancy; father’s age is missing). The distributions of estimated
propensity scores (Figure 2), show a good overlap of the propensity scores of mothers
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who smoked during their pregnancy and those who did not. However, a large number of
propensity score values are near 0, suggesting potential problems from extreme weights.
This motivates potential gains from balancing weights (trimming, OW, MW, EW) be-
yond standard IPW. Applying these methods we find that good covariate balance is
achieved between the two exposure groups for all balancing weights (Figure 3).
Estimated Propensity Score
0.0 0.2 0.4 0.6 0.8 1.0
Smoker
Nonsmoker
Min. 1st Qu. Median Mean 3rd Qu. Max.
Smoker 0.0016 0.06 0.11 0.15 0.19 0.85
Nonsmoker 0.0001 0.03 0.05 0.07 0.08 0.83
Figure 2: NC birth weights: Distribution of estimated propensity scores
Next, each of the balancing weights is used to estimate the corresponding weighted-
average treatment effect defined by equation (2). Assuming that the propensity score
model is correctly specified, the point estimates and confidence intervals are displayed
in Figure 4. The conclusion is the same across the different analyses: birth weights
are lower if the mothers smoked than not. However, the estimated magnitude ranges
from -122 grams (IPW) to -147 grams (IPW with trimming at 0.15), and the confidence
intervals differ substantially. As expected, OW was the most efficient (the smallest
standard error) [17, 20, 42], while IPW was the least efficient.
Note that trimming further inflates the standard error of IPW estimates by excluding
from the original sample a large proportion of mothers with estimated propensity scores
near 0. This can be seen in the resulting standard errors, but also prior to analysis
of outcome through a “design effect” approximation of Kish [20]. This approximate
9
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Method
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Figure 4: NC birth weight: Forest plot
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variance inflation is reported in Table 2.
VI =
N1(1−N1)
N

N∑
i=1
Ziw(xi)
2
(
N∑
i=1
Ziw(xi)
)2 +
N∑
i=1
(1− Zi)w(xi)2(
N∑
i=1
(1− Zi)w(xi)
)2
 , for N1 =
N∑
i=1
Zi. (6)
Out of 157, 988 mothers, 130, 515 (82.6%) of them would be trimmed with the cutoff
of 0.10. Therefore, excluding these mothers from the analysis using Crump’s optimal
threshold of 0.10 [14] leads to an estimate of the ATE equal to -144.73 grams (SE = 8.14
grams). In this case, optimal trimming does not reduce standard error of IPW estimate,
suggesting that the performance of trimming is inconsistent. In addition, 79, 182 (50%)
and 144, 974 (91.8%) mothers would be excluded using, respectively, the cutoffs of 0.05
and 0.15, both resulting in considerable reduction of sample size and large variation in
the causal effect estimate. The estimates go from -136.32 (SE = 6.19 grams) to -147.63
(SE = 10.76 grams) when the threshold changes from 0.05 to 0.15.
Table 2: Sample size, variance inflation, estimate and standard error of NC birth weight
data
IPW IPW(0.05) IPW(0.1) IPW(0.15) OW MW EW
n 157,988 78,806 27,473 13,014 157,988 157,988 157,988
% 100 49.9 17.4 8.2 100 100 100
VI 1.67 1.66 2.85 4.80 1.12 1.14 1.14
∆̂h -122.35 -136.03 -144.11 -146.96 -132.77 -133.50 -130.49
SE 6.46 6.18 8.14 10.68 5.01 5.10 5.05
n: trimmed sample size (when applicable); %: percentage of data used (out of N = 157, 988); SE: standard error.
VI: variance inflation; ∆̂h: point estimate of causal treatment effect; SE: standard error.
As demonstrated in the example, the balancing weights that target patients for whom
there is treatment equipoise (OW, MW, EW) exhibit preferable statistical properties in
terms of good covariate balances and superior precision. These would seem to be superior
methods to handle tails in the propensity score distribution. However, we can not rule
out mis-specification in the propensity score model. Are the apparent gains associated
with OW, MW and EW achieved by sacrificing robustness to mis-specification? Even if
the propensity score model is misspecified, we hope the appealing statistical properties
of these balancing weights continue to exist and our choice of propensity score weighting
method is robust. To investigate how robust are the balancing weights (OW, MW, EW)
under various propensity score model misspecifications, different degrees of propensity
score overlap, and different sample sizes.
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4 Simulation studies
4.1 Our objectives
Several simulation studies have been already conducted to assess the performance of
IPW under propensity score misspecification [7, 6, 18, 43] or practical violations of the
positivity assumption [8, 7, 44]. Building upon these investigations, our objective is to
investigate how robust are the OW, MW, and EW to PS model misspecifications and 3
degrees of PS overlap (good, moderate, or poor), for N = 500, 1000, and 2000.
4.2 Simulation setup
We considered both medium and low prevalence of treatment (see Table 3) and carried
out extensive simulation studies using two different data generating processes (DGPs),
for each of the intended PS model misspecifications. For each DGP, we generated a
total of 1,000 simulated datasets. Throughout the simulations, we calculated the true
estimands for IPW, OW, MW, and EW under heterogeneous treatment effect using
”super-populations” of size 107 units, based on the true parameter coefficients, covari-
ates, and models.
4.2.1 Variable omission.
We generated X = (X1, . . . , X6) and Z following the DGP of Li and Greene [23], with
X4 ∼ Ber(0.5), X3 ∼ Ber(0.4 + 0.2X4), X5 = X21 , X6 = X2X4,
where
(
X1
X2
)
∼ N
[(
X4 −X3 + 0.5X3X4
−X4 +X3 +X3X4
)
,
(
2−X3 0.25(1 +X3)
0.25(1 +X3) 2−X3
)]
,
and Z ∼ Bernoulli(e(X)), where e(X) = [1 + exp{−(β0 + β1X1 + · · ·+ β6X6)}]−1.
We considered, respectively, (β0, β1, . . . , β6) = (−0.5, 0.3, 0.4, 0.4, 0.4, −0.1, −0.1),
(−1, 0.6, 0.8, 0.8, 0.8, −0.2, −0.2), and (−1.5, 0.9, 1.2, 1.2, 1.2, −0.3, −0.3) for good,
moderate, and poor overlap of PS distributions, as shown in Figure 5. For low preva-
lence of treatment, we simply changed the intercept β0 to −1.5, −3, and −4 for good,
moderate, and poor PS overlaps (see Figure E.1).
We chose ∆ = 1 (resp. ∆ = −4e(X)2 + 3.94e(X) + 0.69) for a homogeneous (resp.
heterogeneous) treatment effect. Then, we generated the outcome Y ∼ 0.5 + ∆Z+X1 +
0.6X2 +2.2X3 +1.2X4 +0.1X5 +X6 +N(0, 1). Finally, to misspecify the true PS model,
we omitted (one at a time) the variables X2, X5 = X
2
1 , and X6 = X2X4.
4.2.2 Variable transformation.
We generated X = (X1, . . . , X5) and Z such that(
X1
X2
)
∼ N
[(
2
4
)
,
(
1 0.2
0.2 1
)]
,
(
X3
X4
)
∼ N
[(
2
4
)
,
(
1 0.2
0.2 1
)]
, X5 = X
2
1 ,
12
Good Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
20
0
10
0
0
10
0
20
0
0.2 0.4 0.6 0.8
Moderate Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
20
0
10
0
0
10
0
20
0
0.2 0.4 0.6 0.8
Poor Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
40
0
20
0
0
20
0
40
0
60
0
80
0
0.2 0.4 0.6 0.8Good Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
10
0
0
10
0
20
0
0 0.2 0.4 0.6 0.8 1
Moderate Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
0
20
0
40
0
60
0
80
0
10
00
0 0.2 0.4 0.6 0.8 1
Poor Overlap
Propensity Score
Fr
eq
ue
nc
y
Z=0
Z=1
0
50
0
15
00
20
00
0 0.2 0.4 0.6 0.8 1
Figure 5: Histograms of the propensity scores from simulated data, with good (left),
moderate (middle), and poor (right) overlap. Variable omission (top panel) and variable
transformation (bottom panel).
and Z ∼ Bernoulli(e(X)), where e(X) = [1 + exp{−(β0 + β1X1 + · · ·+ β5X5)}]−1.
Under medium treatment prevalence (see Table 3), we chose (β0, β1, . . . , β5) = (−0.2,
0.3, 0.15, 0.22, 0.15, −0.15), (−0.4, 0.6, 0.3, 0.44, 0.3, −0.3), and (−0.6, 0.9, 0.45, 0.66,
0.45, −0.45), respectively, to obtain good, moderate, and poor PS distributions overlap
(Figure 5). For low prevalence of treatment, we change the intercept β0 into −1.5, −2.5,
and −3.5, respectively, for good, moderate, and poor overlap (see Figure E.1).
We generated the outcome Y ∼ 9 + ∆Z+ 0.1X1−0.05(X2 − X3 + X4)+N(0, 1),
with ∆ = 1 and ∆ = −4e(X)2 + 3.94e(X) + 0.69, respectively, for homogeneous
and heterogeneous treatment effects. Finally, we considered the misspecified PS model,
e˜(X)) = [1+exp{−(β0+β1M1+ · · ·+β4M4)}]−1 where M2 = X2(1+X1)+10 and M3 =
(0.04X3 + 0.6)
2, following the DGPs of Kang and Schafer and Kreif et al.[6, 43] We used,
respectively, (M1,M4) =
(
exp(0.1X1), (X4 + 20)
2
)
and
(
exp (0.33X1) , (0.1X2 +X4 + 20)
2
)
for mild and major PS model misspecifications.
4.3 Simulation results
We summarize the results in terms of relative bias, root mean squared error (RMSE),
empirical standard deviation (SD), average estimated standard error (SE), and coverage
probability (CP) of the 95% confidence interval. To be concise, we only present here
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Table 3: Average treatment prevalence for different levels of PS overlap.
Medium prevalence Low prevalence
PS misspecification Good ModeratePoor Good ModeratePoor
Variable omission 47.42% 47.34% 47.12% 27.7% 18.07% 17.99%
Variable transformation 40.76% 37.63% 37.00% 18.51% 12.79% 10.87%
the results for N = 2000 under heterogeneous treatment effect (see Tables 4–5). We
report, in the Appendix, the results for N = 2000 under homogeneous treatment effect
(Section C.1) and the corresponding boxplots of relative biases (Section C) as well as
the additional results for N = 500 and N = 1000 (Section D) and under low prevalence
of treatment for N = 2000 (Section E).
4.3.1 Variable omission.
The results under variable omission are shown in Table 4. Among all the methods and
in almost all the situations we considered, IPW is more sensitive to poorer overlap and
PS model misspecification. When overlap is good and the model is correctly specified,
IPW, as well as the other methods, provides satisfactory estimation with small bias and
variance. However, when overlap worsens, even in the scenarios where the propensity
scores are estimated appropriately, the relative bias and standard error of IPW estimates
increase rapidly and can be much higher than those of the other methods. IPW is also
shown to be less accurate and efficient when the propensity score model is misspecified.
This is true especially under moderate and poor overlap. In a few number of cases, the
difference in bias among IPW estimand and the other methods can be minute given the
fact that the relative bias in Table 4 is presented on 10−2 scale; however, the difference
in standard error is substantial and not to be neglected.
While IPW performs poorly, the weighting methods that target the clinical equipoise
(OW, MW, and EW) maintain their ability to estimate causal effects with relatively
small bias and small variance when X21 and X2X4 are omitted. IPW trimming reduces
the relative bias and standard error of IPW estimates, but is often slightly less accurate
and less efficient compared to OW, MW, and EW. For example, the standard error of
optimal trimming estimate is roughly 1.3 times higher than that of the OW estimate
across the majority of the scenarios. Of all the IPW trimming methods we considered,
the optimal IPW trimming (with the cutoff α = 0.1) was the usually most reliable and
the most efficient. In general, OW, MW, and EW exhibit stronger stability and higher
efficiency against propensity score model misspecifications compared to IPW.
These findings are true except when we omit the main variable X2. As expected,
none of the methods we considered provide satisfactory results and the relative advan-
tage of IPW over the other methods is trivial, considering the magnitudes of the bias and
standard error. In fact because X2 is a strong confounder of the treatment–outcome re-
lationship, excluding it from a postulated PS model lead to unreliable results, regardless
of the method considered and the degree of the overlap of the PS distributions between
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Table 4: Variable omission: heterogeneous treatment effect (N = 2000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 -0.20 8.42 8.42 7.72 0.94 12.12 19.96 7.61 7.16 0.25
IPW(0.05) Good 1.53 -0.09 6.63 6.63 6.71 0.95 12.05 19.55 6.63 6.63 0.23
IPW(0.1) Good 1.53 -0.10 5.82 5.82 5.95 0.96 11.80 19.09 6.08 6.18 0.17
IPW(0.15) Good 1.54 -0.10 5.38 5.38 5.54 0.95 11.29 18.38 5.82 5.92 0.17
OW Good 1.55 -0.08 4.77 4.77 4.83 0.95 11.90 19.20 5.37 5.43 0.08
MW Good 1.56 -0.06 5.01 5.01 5.06 0.95 12.18 19.87 5.65 5.70 0.08
EW Good 1.54 -0.10 4.88 4.88 4.95 0.95 11.91 19.17 5.41 5.48 0.09
IPW Mod 1.32 -0.13 31.09 31.11 21.66 0.84 24.78 38.18 19.58 15.72 0.34
IPW(0.05) Mod 1.36 0.38 10.79 10.78 10.51 0.93 21.92 31.67 10.47 10.26 0.19
IPW(0.1) Mod 1.42 0.25 7.56 7.56 7.64 0.95 20.59 30.15 7.68 7.76 0.04
IPW(0.15) Mod 1.47 0.01 6.85 6.85 6.70 0.94 20.18 30.62 7.19 6.96 0.02
OW Mod 1.44 -0.14 5.61 5.61 5.58 0.95 23.00 33.63 6.17 6.07 0.00
MW Mod 1.47 -0.26 5.90 5.89 5.88 0.95 23.29 34.88 6.52 6.44 0.00
EW Mod 1.42 -0.13 6.03 6.03 6.01 0.94 22.98 33.17 6.38 6.29 0.00
IPW Poor 1.17 9.16 53.33 52.27 35.56 0.74 39.82 58.20 34.89 26.91 0.42
IPW(0.05) Poor 1.29 0.85 11.55 11.50 11.49 0.94 29.66 39.99 11.16 11.17 0.11
IPW(0.1) Poor 1.39 0.57 8.65 8.62 8.35 0.94 28.77 40.95 8.30 8.24 0.00
IPW(0.15) Poor 1.47 0.23 7.76 7.76 7.80 0.95 27.36 40.91 7.79 7.74 0.00
OW Poor 1.38 0.29 6.32 6.31 6.40 0.95 32.25 44.94 6.41 6.66 0.00
MW Poor 1.42 0.22 6.60 6.60 6.75 0.96 31.98 46.05 6.78 7.03 0.00
EW Poor 1.34 0.40 7.02 7.01 7.10 0.95 32.43 44.12 6.79 7.07 0.00
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 -4.27 9.38 6.76 6.76 0.86 -2.85 9.79 8.77 8.07 0.94
IPW(0.05) Good 1.53 -4.52 9.63 6.73 6.71 0.85 -2.91 8.74 7.53 7.40 0.92
IPW(0.1) Good 1.53 -4.94 9.85 6.29 6.32 0.78 -3.05 8.44 7.03 6.88 0.90
IPW(0.15) Good 1.54 -4.87 9.44 5.70 5.79 0.76 -3.09 8.15 6.62 6.54 0.89
OW Good 1.55 -4.08 7.99 4.89 4.93 0.75 -2.77 7.24 5.82 5.70 0.88
MW Good 1.56 -3.69 7.68 5.07 5.11 0.81 -2.46 6.97 5.81 5.75 0.90
EW Good 1.54 -4.19 8.17 4.99 5.04 0.75 -2.84 7.38 5.94 5.82 0.89
IPW Mod 1.32 -14.10 29.30 22.60 20.11 0.92 -5.90 28.22 27.14 21.18 0.94
IPW(0.05) Mod 1.36 -11.28 19.41 11.85 11.34 0.78 -6.43 14.74 11.85 11.80 0.90
IPW(0.1) Mod 1.42 -8.86 14.84 7.94 7.80 0.65 -4.46 10.63 8.56 8.50 0.89
IPW(0.15) Mod 1.47 -8.25 13.95 6.84 6.74 0.55 -3.57 9.19 7.54 7.41 0.89
OW Mod 1.44 -7.65 12.33 5.59 5.62 0.49 -4.42 9.06 6.46 6.31 0.81
MW Mod 1.47 -6.97 11.74 5.72 5.81 0.57 -3.81 8.60 6.53 6.38 0.85
EW Mod 1.42 -8.60 13.65 6.17 6.15 0.48 -4.93 9.86 6.96 6.86 0.82
IPW Poor 1.17 -32.06 71.18 60.52 45.66 0.92 -5.26 51.92 51.58 38.64 0.89
IPW(0.05) Poor 1.29 -14.56 22.25 11.83 11.98 0.68 -6.52 15.36 12.84 12.30 0.91
IPW(0.1) Poor 1.39 -12.51 19.36 8.42 8.46 0.46 -4.25 10.83 9.07 8.96 0.90
IPW(0.15) Poor 1.47 -11.73 18.89 7.75 7.70 0.39 -3.43 9.63 8.21 8.30 0.91
OW Poor 1.38 -11.03 16.53 6.46 6.36 0.33 -4.91 9.68 6.93 7.05 0.85
MW Poor 1.42 -10.06 15.76 6.57 6.53 0.41 -4.06 9.05 6.97 7.17 0.89
EW Poor 1.34 -12.95 19.03 7.68 7.34 0.35 -6.04 11.36 7.95 8.03 0.85
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage×100; RMSE: root mean-squared error×100; SD: empirical standard deviation×100; SE: average estimated
standard error×100; CP: 95% coverage probability. The results are based on 1000 simulated data sets.
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Table 5: Variable transformation: heterogeneous treatment effect (N = 2000).
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.46 0.30 6.12 6.11 5.82 0.95 2.17 6.75 5.96 5.65 0.91 2.56 7.66 6.69 6.01 0.88
IPW(0.05) Good 1.47 0.29 5.55 5.54 5.36 0.95 1.47 5.99 5.59 5.34 0.93 1.93 6.18 5.49 5.30 0.91
IPW(0.1) Good 1.50 0.29 5.43 5.42 5.24 0.95 0.77 5.44 5.32 5.23 0.95 1.12 5.61 5.35 5.19 0.94
IPW(0.15) Good 1.53 0.25 5.45 5.44 5.25 0.95 0.43 5.30 5.26 5.24 0.96 0.76 5.38 5.25 5.19 0.95
OW Good 1.52 0.22 5.19 5.18 5.06 0.95 0.91 5.32 5.14 5.03 0.94 1.42 5.53 5.09 5.00 0.93
MW Good 1.54 0.20 5.25 5.25 5.12 0.95 0.66 5.27 5.18 5.09 0.95 1.16 5.43 5.14 5.05 0.93
EW Good 1.51 0.24 5.20 5.19 5.07 0.95 1.10 5.42 5.16 5.05 0.93 1.61 5.67 5.12 5.01 0.92
IPW Mod 1.24 0.10 15.00 15.01 10.53 0.91 3.54 16.89 16.32 12.47 0.85 2.94 27.44 27.21 18.24 0.84
IPW(0.05) Mod 1.35 0.13 6.85 6.86 6.66 0.94 1.88 7.26 6.81 6.75 0.93 2.39 7.35 6.60 6.59 0.92
IPW(0.1) Mod 1.42 0.15 6.40 6.40 6.44 0.95 1.00 6.45 6.30 6.48 0.96 1.25 6.35 6.10 6.31 0.96
IPW(0.15) Mod 1.48 0.08 6.29 6.30 6.56 0.97 0.29 6.46 6.44 6.58 0.96 0.35 6.10 6.08 6.39 0.97
OW Mod 1.43 0.02 5.72 5.73 5.98 0.97 1.27 5.94 5.66 5.91 0.95 2.01 6.20 5.50 5.77 0.93
MW Mod 1.47 -0.02 5.74 5.74 6.07 0.96 0.80 5.82 5.70 6.00 0.96 1.44 5.92 5.54 5.86 0.95
EW Mod 1.40 0.01 5.82 5.83 6.04 0.96 1.64 6.23 5.79 5.99 0.94 2.44 6.61 5.66 5.86 0.92
IPW Poor 1.10 4.01 18.92 18.40 12.64 0.80 5.76 29.94 29.28 22.12 0.82 5.84 40.87 40.38 41.34 0.84
IPW(0.05) Poor 1.31 0.26 8.21 8.21 7.77 0.93 1.89 8.70 8.34 7.89 0.92 1.77 8.14 7.81 7.57 0.93
IPW(0.1) Poor 1.40 0.01 7.88 7.88 7.58 0.94 0.20 7.61 7.60 7.61 0.95 -0.09 7.24 7.24 7.27 0.94
IPW(0.15) Poor 1.47 -0.11 8.04 8.05 7.81 0.95 -0.57 7.84 7.80 7.79 0.95 -1.16 7.56 7.37 7.39 0.94
OW Poor 1.38 -0.07 7.00 7.01 6.90 0.95 1.20 7.03 6.83 6.75 0.94 1.78 6.95 6.51 6.46 0.93
MW Poor 1.43 -0.15 7.08 7.08 7.01 0.95 0.55 6.89 6.85 6.88 0.95 0.98 6.68 6.54 6.59 0.95
EW Poor 1.35 0.01 7.15 7.15 6.99 0.94 1.78 7.44 7.05 6.90 0.93 2.51 7.49 6.69 6.59 0.91
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage×100; RMSE: root mean-squared error ×100; SD: empirical standard deviation×100; SE: average estimated standard error×100; CP: 95%
coverage probability. The results are based on 1000 simulated data sets.
the treatment groups.
Moreover, some of the coverage probabilities of 95% confidence intervals can be
misleading. Confusion can arise since the coverage probability of IPW is generally better
than OW, MW, EW, and trimming. However, the variance of IPW is tremendous so
that it maintains acceptable coverage even when the bias of IPW is substantial.
Finally, as indicated in Table 4, the range of ”true” values of the estimands un-
der treatment heterogeneity is 1.52–1.56 under good overlap, 1.32–1.47 under moderate
overlap, and 1.17–1.47 under poor overlap. In most scenarios, the true estimands of the
optimal IPW trimming (i.e., with the cutoff α = 0.1) and OW are particularly close in
values, rendering similar target of inference for these two methods.
4.3.2 Variable transformation.
The range of the ”true” values of the estimands, under treatment heterogeneity,
widens as the degree of overlap of the propensity score distributions worsens, going from
1.46–1.54 (good overlap) to 1.24–1.48 (moderate overlap) and 1.10–1.47 (poor overlap).
Yet again, we observe that the true estimands (i.e., the target of inference) of OW
and optimal IPW trimming (α = 0.1) are close to each other. This result provides
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the opportunity to further examine and compare the performances of OW and such an
optimal IPW trimming.
Congruent with the results under variable omission, the results obtained when we
transformed the variables used in the true PS model also lead to the same conclusion as
indicated in Table 5. Indeed, IPW is sensitive to the specification of propensity score
model and the degree of overlap. Under good overlap of propensity score distributions
and correctly specified propensity score models, all the methods lead to similar causal
effect estimates. The biases of different methods are small, corresponding RMSE and
standard errors are also satisfactory and close in values. However, when the overlap of
the distributions of the PS between the treatment groups becomes more and more lim-
ited, going from good to poor, the performance of IPW become very unstable, leading to
more biased estimates and large variability under both minor and major PS model mis-
specifications. The root mean squared error of IPW estimates increases from 6.12×10−2
to 40.87×10−2 in presence of poor overlap and major propensity score misspecification.
This trend can also be observed in other measures in Table 5, including standard error
and coverage probability.
Again, the results in Table 5 demonstrate the robustness of the class of balancing
weights that target clinical equipoise (OW, MW, and EW) against poor overlap and
propensity score model misspecification. For this class of weights, the inflation in bias
and variance is negligible and the ability to maintain satisfactory causal effect estimation
is stable across all scenarios. Again, IPW trimming improves the performance of IPW.
Furthermore, the optimal IPW trimming (with α = 0.1) yields very good results, with
even smaller biases than OW, MW, and EW in most of the scenarios; however, the
standard errors of OW, MW, and EW are consistently smaller. It is worth noting that
in this set of simulations, overall the biases from all methods (IPW, IPW trimming, OW,
MW, and EW) are relatively small in scale and, thus, the variance continues to play a
preeminent role in comparing them.
The appendices C, D, and E include a number of additional simulation settings: (1)
homogenous treatment effects; (2) smaller samples sizes (N = 500 and N = 1000); (3)
low treatment prevalence. Results in these settings were similar to those in Table 4
and Table 5. That is IPW yielded some bias and severely inflated standard errors when
the propensity score distribution had moderate to poor overlap. OW, MW and EW all
performed similarly to each other and moderately better than trimming. All methods
performed poorly when an important confounder (X2) was omitted form the analysis.
In smaller sample sizes and low treatment prevalence, the problems with IPW were even
more pronounced and not always corrected by trimming. The benefit of OW, MW and
EW was more evident in these settings.
5 Discussion
We investigate the impacts of both propensity score misclassification and practical vio-
lations of positivity on OW, MW, and EW compared to IPW and IPW trimming. In
extensive simulations we find that IPW is sensitive to both misspecification of the PS
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model and the degrees of overlap of the PS distributions. Its relative bias and standard
error increase rapidly as the PS model becomes erroneous and as the impact of misspec-
ification enlarges. On the contrary, the changes in relative bias and standard for OW,
MW, and EW, were modest and usually less poignant compared to IPW. Two interesting
facts might explain such a seemingly robustness of these methods. The estimand of OW,
MW, and EW is not defined on the estimated but true PS. Therefore, even when the PS
model is misspecified, the estimand is still well-defined. In fact, this estimand equals the
average treatment effect whenever the treatment effect is constant. Besides, it is com-
monly known that PS misspecification usually matters most in the area of limited PS
distributions overlap or when the propensity scores are near 0 or 1 [17, 20, 42, 11, 7, 45].
Our simulation studies also demonstrated that the weighted average treatment effect
difference is more likely to be affected by a PS model misspecification when treatment
effect is heterogeneous, rather than homogeneous. Because overlap, matching, and en-
tropy weighting smoothly down-weight the influence of observations at both end of PS
spectrum and focus on regions of the distributions the (measured) covariates with the
most overlap, their robustness is expected as it captures the treatment effect where it is
more informative [17].
We also found that by targeting the middle range, IPW trimming can considerably
improve the performance of IPW. Our simulations seem to indicate that trimming at
0.10 is better than trimming at 0.05 or 0.15. However, as it was the case with our
motivating example, it is difficult to optimally determine which cutoff α can provide
the best bias-variance trade-off, despite the cutoff α = 0.10 recommended by Crump et
al.[13, 14] as a good rule-of-thumb. Depending on the data at hand, the sample size,
the degree of PS distributions overlap, as well as the type of misspecification, trimming
at 0.10 is not always better than trimming at 0.15 (or other higher cutpoint). While
increasing the trimming cutpoint seems to decrease the variance of the estimators, there
is no control whatsoever on the amount of bias such a process introduce into the point
estimate.
In practice, various cutoffs α are still being used without a clear rationale as to why
(1) we need to choose a specific cuttoff and (2) we must rather discard observations
outside of the interval [α, 1−α] instead of outside of the α-th and (1−α)-th percentiles
or vice versa [7, 16, 15, 10, 12]. In reality, an efficient and optimal trimming algorithm
requires a clear bias-variance trade-off and cannot be fixed in advance as it is likely to
be data-driven: excessive trimming may improve the variance by removing participants
with extreme weights, but introduce bias and not enough trimming may somehow help
reduce bias, but not improve the variance significantly (or vice-versa). Unfortunately,
such a data-adaptive nature of IPW trimming is also its main drawback as it makes the
related conclusions from IPW trimming subjective susceptible to the arbitrary choice
of cutoffs and mode of trimming (i.e., interval range vs. percentiles), which result in
unclear and unstable causal effect estimation.
In light of these results, for our motivating example on maternal smoking and its
effect on infants’ birth weight, we can confidently rely on the results obtain with OW,
MW, and EW if we factor in the large number of participants with a propensity score
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near 0 and extremely large proportions of participants who would be excluded had we
decide to trim at 0.05 (50% will be excluded), at 0.10 (with 82.6% excluded) or at 0.15
(with 91.8% excluded). In this example, using OW (which has the smallest standard
error), we will conclude that, in our data set, infants born to mothers who smoked while
pregnant weigh, on average, 132.77 grams less than infants born to mothers who did not
smoke.
As illustrated in our motivating example, in practice, only a PS model that passes
overlap and balance checks will be ultimately used to evaluate causal effects. Besides,
it has become ubiquitous that the choice of variables to include in a PS model needs to
be examined carefully. It is recommended that we should only include true confounders,
variables that are directly related to the treatment assignment and the outcome of in-
terest, as well as variables are predictors of the outcome (but not necessarily of the
treatment). Variables that are mediators of the treatment–outcome relationship, only
predictors of the treatment, post-treatment, or time-varying, or treatment dependent
must not be included [46, 47, 48, 16, 49]. As a result, glaring and severe problems of
misspecification are less likely to appear in real-world data analysis. Nevertheless, if
unmeasured confounding is an issue, a sensitivity analysis is highly recommended.
In general, overlap of the PS distributions, balance of the covariates, and inference
can be improved by adding in the PS model higher order and interaction terms [50, 1,
51]. Furthermore, more flexible models or approaches, including generalized additive
model and random forest, may be leveraged to efficiently handle with higher order and
interactions terms in a model and provide valuable information for PS estimation. If
after these preemptive measures, we are still confronted with the limited overlap or the
presence of observations with PSs near 0 or 1 that may jeopardize the validity of our IPW
estimation, our simulation studies clearly highlight situations where alternative methods
such as OW, MW, and EW may be advantageous. In these situations, we recommend
using the inverse weighting methods that target the population of patients for whom
there is a clinical equipoise, i.e., OW, MW, or EW.
In conclusion, one of the key questions that motivated this paper was whether IPW
is better than OW at reducing relative bias while improving efficiency. Overall, our sim-
ulation studies indicate that OW, MW, and EW outperformed IPW, with OW providing
a most efficient estimate.
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Appendix
A Sandwich variance for the estimators
A.1 Sandwich variance for the balancing-weight estimators
The large-sample variance estimator of ∆̂h can be derived using M-theory. In this paper,
we determine the empirical sandwich variance estimator, assuming regularity conditions
hold [28, 29].
Given the function h(x), the estimator ∆̂h can be written as ∆̂h = ∆̂1h− ∆̂0h, where(
∆̂1h, ∆̂0h
)
are the solutions to the estimating equations
N∑
i=1
(
Zih(Xi)
e(Xi)
(Yi −∆1h), (1− Zi)h(Xi)
1− e(Xi) (Yi −∆0h))
)′
= 0,
with respect to (∆1h,∆0h), along with the estimating equation for the logistic regression
parameters β,
ψβ(β,X) =
N∑
i=1
[Zi − e(Xi)]Xi = 0 (A.1)
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where e(X) = P (Z = 1|X) = {1 + exp(−Xβ)}−1.
For the treatment group, i.e., when Z = 1, we have
U(∆̂1h, eˆ(Xi)) =
N∑
i=1
Ziĥ(Xi)
eˆ(Xi)
(Yi − ∆̂1h) = 0
via the first equation. We consider the Taylor’s expansions,
0 = U(∆̂1h, eˆ(Xi)) = U(∆1h, e(Xi)) +
∂U(∆1h, e(Xi))
∂∆1h
(∆̂1h −∆1h) + ∂U(∆1h, e(Xi))
∂β′
(βˆ − β) + op(1)
0 = ψβ(Xi, βˆ) = ψβ(Xi, β) +
∂ψβ(Xi, βˆ)
∂β′
(βˆ − β) + op(1).
⇒

0 =
N∑
i=1
Zih(Xi)
e(Xi)
(Yi −∆1h)−
N∑
i=1
Zih(Xi)
e(Xi)
(∆ˆ1h −∆1h) + Uβ(βˆ − β) + op(1)
0 =
N∑
i=1
[Zi − e(Xi)]Xi −
N∑
i=1
[
e(Xi)(1− e(Xi))XiX ′i
]
(βˆ − β) + op(1)
with Uβ =
∂U(∆1h, e(Xi))
∂β′
=
N∑
i=1
Zi
[
hβ(Xi)− (1− e(Xi))h(Xi)X ′i
]
e(Xi)
(Yi −∆1h)
and hβ(Xi) =
∂h(Xi)
∂β′
⇒

(∆ˆ1h −∆1h) 1
N
N∑
i=1
Zih(Xi)
e(Xi)
=
1
N
[
N∑
i=1
Zih(Xi)
e(Xi)
(Yi −∆1h) + Uβ(βˆ − β)
]
(βˆ − β) 1
N
N∑
i=1
[
e(Xi)(1− e(Xi))XiX ′i
]
=
1
N
N∑
i=1
[Zi − e(Xi)]Xi
⇒

∆ˆ1h −∆1h =
Eˆ−11h
N
[
n∑
i=1
Zih(Xi)
e(Xi)
(Yi −∆1h) + Uβ(βˆ − β)
]
; Eˆ1h =
1
N
N∑
i=1
Zih(Xi)
e(Xi)
βˆ − β = Eˆ
−1
ββ
N
N∑
i=1
[Zi − e(Xi)]Xi; Eˆββ = 1
N
N∑
i=1
[
e(Xi)(1− e(Xi))XiX ′i
]
⇒ ∆ˆ1h −∆1h =
Eˆ−11h
N
N∑
i=1
[
Zih(Xi)
e(Xi)
(Yi −∆1h) + [Zi − e(Xi)] 1
N
UβEˆ
−1
ββXi
]
.
Similarly, for Z = 0, we have V (∆̂0h, eˆ(Xi)) =
N∑
i=1
(1− Zi)ĥ(Xi)
1− eˆ(Xi) (Yi − ∆̂0h) = 0. We
can show that
∆ˆ0h −∆0h =
Eˆ−10h
N
N∑
i=1
[
(1− Zi)h(Xi)
1− e(Xi) (Yi −∆0h) + [Zi − e(Xi)]
1
N
VβEˆ
−1
ββXi
]
;
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Eˆ0h =
1
N
N∑
i=1
(1− Zi)h(Xi)
1− e(Xi) and
Vβ =
∂V (∆0h, e(Xi))
∂β′
=
N∑
i=1
(1− Zi) [hβ(Xi) + e(Xi)h(Xi)X ′i]
(1− e(Xi)) (Yi −∆0h).
Thus,
√
N(∆ˆh −∆h) =
√
N
[
(∆ˆ1h −∆1h)− (∆ˆ0h −∆0h)
]
(A.2)
=
Eˆ−11h√
N
N∑
i=1
[
Zih(Xi)
e(Xi)
(Yi −∆1h)
]
− Eˆ
−1
0h√
N
N∑
i=1
[
(1− Zi)h(Xi)
1− e(Xi) (Yi −∆0h)
]
+
Eˆ−11h√
N
N∑
i=1
[
[Zi − e(Xi)] 1
N
UβEˆ
−1
ββXi
]
− Eˆ
−1
0h
N
N∑
i=1
[
[Zi − e(Xi)] 1
N
VβEˆ
−1
ββXi
]
Note that both Eˆ1h =
1
N
N∑
i=1
Zih(Xi)
e(Xi)
and Eˆ0h =
1
N
N∑
i=1
(1− Zi)h(Xi)
1− e(Xi) converge in
probability to E [h(X)] , by the weak law of large numbers. Indeed,
Eˆ1h −→ E
[
Zh(X)
e(X)
]
= E
[
E
[
Zh(X)
e(X)
∣∣∣X]] = E [h(X)
e(X)
E [Z|X]
]
= E [h(X)] .
Likewise,
Eˆ0h =
1
N
N∑
i=1
(1− Zi)h(Xi)
1− e(Xi) −→ E [h(X)]
in probability. We can replace both Eˆ1h and Eˆ0h by Eˆh =
1
N
N∑
i=1
h(Xi) in (A.2), i.e.,
√
N(∆ˆh −∆h) equals
Eˆ−1h√
N
N∑
i=1
[
Zih(Xi)
e(Xi)
(Yi −∆1h)− (1− Zi)h(Xi)
1− e(Xi) (Yi −∆0h)− [Zi − e(Xi)]
1
N
(Vβ − Uβ) Eˆ−1ββXi
]
Therefore, an approximate sampling variance of ∆ˆh can be computed as
1
N2
N∑
i=1
Iˆ2h where
Iˆh = Eˆ
−1
h
[
Zihˆ(Xi)
eˆ(Xi)
(Yi − ∆ˆ1h)− (1− Zi)hˆ(Xi)
1− eˆ(Xi) (Yi − ∆ˆ0h)− [Zi − eˆ(Xi)]HˆβEˆ
−1
ββXi
]
; Hˆβ =
1
N
(
Vˆβ − Uˆβ
)
.
The normalized IPW is a special case of the balanced weights where the tilting function
h(x) = 1. The sampling variance of ∆ˆ{h=1} is given by
1
N2
N∑
i=1
Iˆ2{h=1} with,
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Iˆ{h=1} =
Zi
eˆ(Xi)
(Yi − ∆ˆ1{h=1})−
(1− Zi)
1− eˆ(Xi)(Yi − ∆ˆ0{h=1})− [Zi − eˆ(Xi)]HˆβEˆ
−1
ββXi
where Hˆβ =
1
N
(Vˆβ−Uˆβ) = 1
N
N∑
i=1
[
(1− Zi)eˆ(Xi)
(1− eˆ(Xi)) (Yi − ∆ˆ0{h=1}) +
Zi(1− eˆ(Xi))
eˆ(Xi)
(Yi − ∆ˆ1{h=1})
]
X ′i
A.2 Sandwich variance for the stabilized IPW estimator
The stabilized IPW estimator, based on Hernan and Robin’s definition [40], is given by
∆ˆs =
1
N
N∑
i=1
[
ZiP (Z = 1)Yi
eˆ(Xi)
− (1− Zi) [1− P (Z = 1)]Yi
1− eˆ(Xi)
]
. (A.3)
Thus, the estimator ∆ˆs can be written as ∆ˆs = ∆ˆ1s−∆ˆ0s, where ∆ˆ1s = 1
N
N∑
i=1
ZiP (Z = 1)Yi
eˆ(Xi)
and ∆ˆ0s =
(1− Zi) [1− P (Z = 1)]Yi
1− eˆ(Xi) are solutions to the (system of) estimating equa-
tions
N∑
i=1
(
ZiP (Z = 1)
e(Xi)
Yi −∆1s, (1− Zi) [1− P (Z = 1)]
1− e(Xi) Yi −∆0s)
)′
= 0,
with respect to (∆1s,∆0s), along with the logistic estimating equation (A.1) of β.
For Z = 1, the equation U s(∆ˆ1s, eˆ(Xi)) =
N∑
i=1
[
ZiP (Z = 1)
eˆ(Xi)
Yi − ∆ˆ1s
]
= 0 leads to
0 =
N∑
i=1
[
ZiP (Z = 1)
e(Xi)
Yi −∆1s
]
−N(∆ˆ1s −∆1s) + U sβ(βˆ − β) + op(1)
via a Taylor’s expansion, with U sβ =
∂U s(∆1s, e(Xi))
∂β′
= −
N∑
i=1
ZiP (Z = 1)(1− e(Xi))
e(Xi)
YiX
′
i.
⇒ ∆ˆ1s −∆1s = 1
N
[
N∑
i=1
(
ZiP (Z = 1)
e(Xi)
Yi −∆1s
)
+ U sβ(βˆ − β)
]
⇒
√
N(∆ˆ1s −∆1s) = 1√
N
N∑
i=1
[(
ZiP (Z = 1)
e(Xi)
Yi −∆1s
)
+ [Zi − e(Xi)] 1
N
U sβEˆ
−1
ββXi
]
since βˆ − β = Eˆ
−1
ββ
N
N∑
i=1
[Zi − e(Xi)]Xi.
Similarly, for the control group where Z = 0, the estimating equation
V s(∆ˆ0s, eˆ(Xi)) =
N∑
i=1
[
(1− Zi) [1− P (Z = 1)]
1− eˆ(Xi) Yi − ∆ˆ0s
]
= 0
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leads to
√
N(∆ˆ0s−∆0s) = 1√
N
[
N∑
i=1
(
(1− Zi) [1− P (Z = 1)]
1− e(Xi) Yi −∆0s
)
+ [Zi − e(Xi)] 1
N
V sβ Eˆ
−1
ββXi
]
where V sβ =
∂V s(∆0s, e(Xi))
∂β′
=
N∑
i=1
(1− Zi) [1− P (Z = 1)] e(Xi)
(1− e(Xi)) YiX
′
i.
⇒
√
N(∆ˆs −∆s) = 1√
N
N∑
i=1
[
ZiP (Z = 1)
e(Xi)
Yi − (1− Zi) [1− P (Z = 1)]
1− e(Xi) Yi −∆s − [Zi − e(Xi)]H
s
βEˆ
−1
ββXi
]
whereHsβ =
1
N
(V sβ−U sβ) =
1
N
N∑
i=1
[
ZiP (Z = 1)(1− e(Xi))
e(Xi)
+
(1− Zi) [1− P (Z = 1)] e(Xi)
(1− e(Xi))
]
YiX
′
i.
Therefore, the empirical sample variance of the estimator ∆ˆs can be estimated by
1
N2
N∑
i=1
Iˆ2s where
Iˆs =
ZiPˆ (Z = 1)
eˆ(Xi)
Yi − (1− Zi) [1− P (Z = 1)]
1− eˆ(Xi) Yi − ∆ˆs − [Zi − eˆ(Xi)]Hˆ
s
βEˆ
−1
ββXi
with Hˆsβ =
1
N
N∑
i=1
[
ZiP (Z = 1)(1− eˆ(Xi))
eˆ(Xi)
+
(1− Zi) [1− P (Z = 1)] eˆ(Xi)
(1− eˆ(Xi))
]
YiX
′
i.
B Asymptotic bias of a regular asymptotic linear (RAL)
estimator
Consider the RAL θ̂, solution to the estimating equation Un(θ) =
N∑
i=1
Uij(Xi, Zi, Yi; θ) =
0, with respect to θ. We use the Taylor’s expansion
0 = Un(θ̂) = Un(θ0) + [∂Un(θ)/∂θ]θ0 (θ̂ − θ0) + op(1),
to derive the asymptotic bias of the estimator θ̂ of θ0, i.e.,
θ̂ − θ0 = −
[
1
N
∂Un(θ)/∂θ
′
]−1
θ0
1
N
{Un(θ0)}+ op(1),
under some regularity conditions. Therefore, the asymptotic bias of the estimator θ̂ is
approximately equal to
−E [∂U(X, Z, Y ; θ0)/∂θ′]−1E {U(X, Z, Y ; θ0)} (B.1)
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C Simulation results, Part I:
Medium treatment prevalence and N = 2000.
C.1 Homogeneous treatment effect
C.1.1 Variable omission and variable transformation
Both Tables C.1 and C.2 show the results under misspecified PS model using a constant
treatment effect and a simple size of 2,000 observations.
Figures C.1 and C.3 show the boxplots of the relative bias percentages for the different
PS weighting methods, under variable omissions. Similarly, both C.5 and C.6, represent
the boxplots of relative bias percentages, when true variables are transformed as specified
in the main text. For better visualization, we trimmed some outlying IPW relative bias
percentage estimates beyond 50%. The intervals indicate the ranges of the IPW relative
bias estimates in these situations where some of the outlying values did not fit on the
graphs.
Table C.1: Variable transformation: homogeneous treatment effect (N = 2000).
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSESD SE CP Bias RMSESD SE CP Bias RMSESD SE CP
IPW Good 1 -0.12 5.52 5.52 5.61 95 -0.16 5.46 5.46 5.53 95 -0.41 6.70 6.69 5.99 96
IPW(0.05) Good 1 -0.14 5.11 5.11 5.28 96 0.11 5.12 5.13 5.26 96 0.55 5.05 5.03 5.20 95
IPW(0.1) Good 1 -0.17 5.07 5.07 5.20 95 0.23 5.10 5.10 5.17 95 0.72 5.04 4.99 5.13 95
IPW(0.15) Good 1 -0.15 5.07 5.07 5.22 95 0.24 5.01 5.01 5.19 96 0.77 5.03 4.98 5.14 95
OW Good 1 -0.19 4.87 4.87 5.01 96 0.13 4.83 4.83 4.98 96 0.89 4.84 4.76 4.94 95
MW Good 1 -0.20 4.93 4.93 5.08 96 0.07 4.88 4.88 5.04 96 0.98 4.92 4.83 5.01 95
EW Good 1 -0.18 4.87 4.87 5.02 96 0.12 4.84 4.84 4.99 96 0.79 4.84 4.78 4.96 95
IPW Mod 1 0.07 14.45 14.46 9.78 93 -0.47 15.27 15.27 11.96 95 -4.69 27.60 27.21 18.29 96
IPW(0.05) Mod 1 0.10 6.62 6.63 6.54 94 0.57 6.81 6.79 6.63 94 1.13 6.68 6.59 6.46 94
IPW(0.1) Mod 1 0.24 6.40 6.40 6.38 95 0.52 6.50 6.48 6.39 95 1.47 6.50 6.33 6.23 94
IPW(0.15) Mod 1 0.11 6.60 6.61 6.53 95 0.42 6.67 6.66 6.52 95 1.54 6.57 6.39 6.33 95
OW Mod 1 0.09 5.92 5.92 5.88 95 0.45 5.88 5.86 5.80 95 1.89 6.02 5.72 5.67 94
MW Mod 1 0.09 5.98 5.98 6.00 95 0.35 5.91 5.90 5.92 96 2.08 6.13 5.77 5.78 94
EW Mod 1 0.08 6.00 6.00 5.93 95 0.44 5.98 5.96 5.87 95 1.63 6.03 5.81 5.74 94
IPW Poor 1 0.44 20.56 20.56 12.55 90 -2.42 33.03 32.96 23.37 93 -8.45 44.12 43.32 43.19 96
IPW(0.05) Poor 1 0.11 7.86 7.87 7.66 94 0.69 7.95 7.92 7.76 94 1.95 8.02 7.79 7.45 93
IPW(0.1) Poor 1 0.12 7.73 7.74 7.51 94 0.65 7.76 7.73 7.53 94 2.00 7.70 7.44 7.17 93
IPW(0.15) Poor 1 0.10 8.06 8.07 7.77 95 0.54 8.00 7.98 7.72 94 2.15 7.88 7.58 7.32 93
OW Poor 1 0.10 6.95 6.95 6.75 94 0.59 6.89 6.87 6.61 94 2.63 7.11 6.61 6.32 91
MW Poor 1 0.11 7.06 7.06 6.89 94 0.51 7.00 6.99 6.76 94 2.84 7.30 6.72 6.47 91
EW Poor 1 0.08 7.05 7.06 6.82 95 0.54 7.04 7.03 6.75 94 2.19 7.10 6.76 6.46 93
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage×100; RMSE: root mean-squared error×100; SD: empirical standard deviation×100; SE: average estimated standard error×100;
CP: 95% coverage probability×100. The results are based on 1000 simulated data sets.
28
Table C.2: Variable omission: homogeneous treatment effect (N = 2000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 -0.18 8.03 8.04 7.20 93 17.35 18.85 7.36 6.81 27
IPW(0.05) Good 1 -0.14 6.61 6.61 6.40 94 17.37 18.56 6.53 6.39 23
IPW(0.1) Good 1 -0.19 5.93 5.93 5.79 95 17.38 18.42 6.09 6.04 19
IPW(0.15) Good 1 -0.17 5.63 5.63 5.47 95 17.23 18.18 5.80 5.83 16
OW Good 1 -0.04 4.91 4.91 4.81 95 18.31 19.09 5.38 5.37 8.0
MW Good 1 0.08 5.11 5.11 5.06 95 19.44 20.24 5.63 5.65 7.0
EW Good 1 -0.08 5.03 5.04 4.88 95 18.06 18.86 5.44 5.40 8.0
IPW Mod 1 0.55 28.01 28.02 19.59 86 29.02 34.24 18.20 14.62 37
IPW(0.05) Mod 1 0.65 10.09 10.08 10.12 95 28.05 29.74 9.88 9.96 22
IPW(0.1) Mod 1 0.36 7.24 7.23 7.49 96 28.95 29.84 7.23 7.59 4.0
IPW(0.15) Mod 1 0.34 6.52 6.52 6.62 96 31.53 32.27 6.84 6.83 00
OW Mod 1 0.24 5.47 5.47 5.48 95 33.62 34.13 5.90 5.94 00
MW Mod 1 0.14 5.89 5.89 5.84 96 36.19 36.74 6.35 6.34 00
EW Mod 1 0.24 5.77 5.77 5.80 95 32.31 32.87 6.05 6.10 00
IPW Poor 1 10.11 49.47 48.45 33.16 76 39.74 50.43 31.06 25.53 48
IPW(0.05) Poor 1 0.54 10.75 10.74 11.12 95 36.40 38.00 10.91 10.91 11
IPW(0.1) Poor 1 0.36 7.91 7.91 8.18 96 42.27 43.01 7.92 8.11 00
IPW(0.15) Poor 1 0.18 7.55 7.56 7.72 96 46.53 47.17 7.77 7.70 00
OW Poor 1 0.14 6.07 6.07 6.25 95 46.39 46.83 6.35 6.53 00
MW Poor 1 0.11 6.50 6.50 6.65 96 49.69 50.15 6.76 6.96 00
EW Poor 1 0.27 6.56 6.56 6.83 96 43.89 44.38 6.56 6.88 00
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 -7.49 10.14 6.84 6.58 80 -4.54 9.76 8.64 7.75 91
IPW(0.05) Good 1 -7.60 10.20 6.81 6.55 78 -4.67 9.00 7.70 7.23 90
IPW(0.1) Good 1 -7.88 10.17 6.43 6.22 75 -4.82 8.72 7.27 6.83 88
IPW(0.15) Good 1 -7.55 9.60 5.94 5.74 73 -4.81 8.42 6.92 6.55 88
OW Good 1 -6.45 8.18 5.04 4.94 74 -4.33 7.45 6.07 5.75 87
MW Good 1 -5.67 7.67 5.17 5.13 79 -3.78 7.08 6.00 5.80 89
EW Good 1 -6.75 8.49 5.16 5.02 73 -4.45 7.65 6.22 5.85 87
IPW Mod 1 -20.89 30.11 21.69 19.29 89 -8.09 25.91 24.63 19.59 95
IPW(0.05) Mod 1 -16.24 19.64 11.06 10.97 72 -8.96 14.43 11.31 11.56 92
IPW(0.1) Mod 1 -12.61 14.69 7.55 7.66 64 -6.64 10.64 8.32 8.43 89
IPW(0.15) Mod 1 -10.82 12.67 6.59 6.69 64 -5.00 8.97 7.44 7.39 90
OW Mod 1 -10.66 12.03 5.58 5.55 52 -6.25 9.00 6.48 6.31 82
MW Mod 1 -9.39 11.07 5.87 5.79 61 -5.37 8.51 6.61 6.39 85
EW Mod 1 -12.23 13.63 6.02 6.00 46 -6.97 9.82 6.92 6.80 82
IPW Poor 1 -41.09 70.73 57.60 44.13 93 -7.73 48.79 48.20 36.74 90
IPW(0.05) Poor 1 -19.65 22.47 10.90 11.60 63 -9.76 15.50 12.05 12.07 89
IPW(0.1) Poor 1 -16.14 18.01 7.99 8.29 52 -6.37 10.80 8.72 8.88 90
IPW(0.15) Poor 1 -14.44 16.29 7.54 7.63 53 -4.78 9.58 8.31 8.26 90
OW Poor 1 -14.65 15.86 6.10 6.23 34 -7.41 10.10 6.87 6.96 82
MW Poor 1 -12.98 14.47 6.39 6.47 48 -6.25 9.41 7.04 7.12 86
EW Poor 1 -17.49 18.80 6.90 7.09 30 -8.88 11.76 7.72 7.87 81
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage×100; RMSE: root mean-squared error×100; SD: empirical standard deviation×100; SE: average estimated
standard error×100; CP: 95% coverage probability×100. The results are based on 1000 simulated data sets.
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Figure C.1: Variable omission: Relative bias (homogeneous treatment effect), with N =
2000.
Legend: A: Correct PS Model; B: Missing X21 ; C: Missing X2X4; D: Missing X2.
D Simulation results, Part II:
Medium prevalence, N = 500 and N = 1000.
D.1 Under variable omission
Tables D.1 and D.2 (resp. Tables D.3 and D.4) provide the results under variable omis-
sion for N = 500 (resp. N = 1000) for homogeneous as well as heterogeneous treatment
effects.
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Table D.1: Variable omission: homogeneous treatment effect (N = 500).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 1.15 15.02 14.98 13.97 0.93 18.51 23.26 14.10 13.38 0.65
IPW(0.05) Good 1 0.58 13.02 13.01 12.95 0.94 18.20 22.40 13.07 12.88 0.67
IPW(0.1) Good 1 0.51 11.48 11.47 11.81 0.96 17.91 21.58 12.05 12.28 0.67
IPW(0.15) Good 1 0.26 10.66 10.66 11.12 0.95 17.59 21.00 11.48 11.80 0.67
OW Good 1 0.12 9.58 9.59 9.60 0.95 18.33 21.20 10.66 10.73 0.58
MW Good 1 0.06 10.14 10.15 10.30 0.95 19.23 22.28 11.24 11.43 0.61
EW Good 1 0.23 9.69 9.69 9.73 0.95 18.23 21.16 10.75 10.77 0.58
IPW Mod 1 6.76 41.11 40.57 29.41 0.82 32.51 43.49 28.91 24.93 0.56
IPW(0.05) Mod 1 1.22 19.76 19.73 19.65 0.94 29.44 34.96 18.87 19.34 0.61
IPW(0.1) Mod 1 0.07 14.59 14.59 15.24 0.95 29.74 33.11 14.56 15.39 0.49
IPW(0.15) Mod 1 -0.44 13.21 13.21 13.67 0.96 31.55 34.44 13.83 14.11 0.40
OW Mod 1 -0.32 11.03 11.03 10.97 0.95 33.63 35.64 11.80 11.90 0.19
MW Mod 1 -0.38 11.77 11.77 11.89 0.95 36.05 38.19 12.61 12.83 0.19
EW Mod 1 -0.07 11.58 11.59 11.51 0.95 32.54 34.69 12.02 12.16 0.23
IPW Poor 1 22.03 73.18 69.81 46.42 0.70 45.14 73.19 57.64 41.55 0.56
IPW(0.05) Poor 1 0.41 21.97 21.98 22.09 0.94 37.38 43.34 21.95 21.65 0.53
IPW(0.1) Poor 1 0.20 16.24 16.24 16.84 0.95 43.02 46.06 16.48 16.54 0.26
IPW(0.15) Poor 1 0.21 16.69 16.70 15.99 0.94 47.05 49.67 15.94 15.77 0.16
OW Poor 1 -0.38 12.73 12.73 12.47 0.94 46.41 48.25 13.20 13.08 0.06
MW Poor 1 -0.24 13.38 13.38 13.54 0.95 49.72 51.64 13.96 14.08 0.06
EW Poor 1 -0.14 14.10 14.11 13.48 0.93 43.96 46.18 14.14 13.67 0.12
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 -6.79 14.91 13.28 13.55 0.94 -3.24 16.02 15.70 15.10 0.94
IPW(0.05) Good 1 -6.86 14.78 13.10 13.33 0.94 -3.88 15.11 14.61 14.48 0.94
IPW(0.1) Good 1 -7.05 13.97 12.06 12.49 0.93 -4.27 14.18 13.53 13.72 0.94
IPW(0.15) Good 1 -6.82 13.05 11.14 11.54 0.92 -4.59 13.63 12.84 13.10 0.94
OW Good 1 -6.23 11.55 9.73 9.85 0.91 -4.27 12.30 11.54 11.49 0.94
MW Good 1 -5.69 11.67 10.20 10.34 0.92 -3.89 12.37 11.75 11.77 0.95
EW Good 1 -6.42 11.72 9.82 10.03 0.90 -4.22 12.41 11.68 11.65 0.93
IPW Mod 1 -17.49 46.50 43.11 33.13 0.94 -3.73 40.73 40.58 31.99 0.89
IPW(0.05) Mod 1 -15.26 26.15 21.25 21.23 0.94 -9.29 24.33 22.50 22.54 0.95
IPW(0.1) Mod 1 -13.08 19.87 14.97 15.41 0.90 -7.44 18.61 17.07 17.02 0.93
IPW(0.15) Mod 1 -11.66 18.00 13.72 13.67 0.86 -6.07 16.33 15.17 15.02 0.93
OW Mod 1 -11.22 15.81 11.14 11.10 0.81 -6.97 14.42 12.63 12.61 0.90
MW Mod 1 -9.93 15.32 11.68 11.71 0.86 -6.01 14.09 12.75 12.97 0.93
EW Mod 1 -12.53 17.38 12.04 11.88 0.82 -7.51 15.55 13.62 13.50 0.90
IPW Poor 1 -24.21 91.54 88.32 59.87 0.87 3.33 78.12 78.09 54.09 0.80
IPW(0.05) Poor 1 -18.70 29.62 22.98 22.88 0.92 -
10.51
26.07 23.87 23.84 0.94
IPW(0.1) Poor 1 -15.16 22.54 16.68 16.70 0.87 -6.13 18.75 17.73 18.00 0.95
IPW(0.15) Poor 1 -14.37 21.10 15.46 15.45 0.85 -4.61 17.74 17.14 16.81 0.93
OW Poor 1 -14.92 19.52 12.59 12.42 0.77 -7.74 15.97 13.98 13.90 0.90
MW Poor 1 -13.45 18.66 12.94 13.05 0.83 -6.44 15.48 14.09 14.44 0.93
EW Poor 1 -17.27 22.57 14.54 13.82 0.76 -9.08 18.45 16.07 15.52 0.91
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error
in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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D.2 Under variable transformation
Tables D.5 and D.6 provide the results under variable transformation for N = 500 and
N = 1000, respectively.
E Simulation results, Part III: Low treatment prevalence
In this section, we present the results under low prevalence of treatment (as indicated
in Table E.1), respectively, under variable omission and under variable transformation
(see Figure E.1) when N = 2000. We consider both homogeneous and heterogeneous
treatment effects.
Tables E.2 and E.3 show the results for variable omission whereas Table E.4 shows the
results for variable transformation under both homogeneous and heterogeneous treat-
ment effects. The boxplots of relative bias percentages for variable omission are shown
in Figures E.2 and E.4; those for variable transformation are shown in Figures E.6 and
E.7
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Figure C.3: Variable omission: Relative bias (heterogeneous treatment effect), with
N = 2000.
Legend: A: Correct PS Model; B: Missing X21 ; C: Missing X2X4; D: Missing X2.
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Figure C.5: Variable Transformation: Relative bias (homogeneous treatment effect),
with N = 2000.
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Figure C.6: Variable Transformation: Relative bias (Heterogeneous treatment effect) ,
with N = 2000.
Legend: A: Correct PS Model; B: Mild PS Model Misspecification; C: Major PS Model Mis-
specification.
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Table D.2: Variable omission: heterogeneous treatment effect (N = 500).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 0.34 17.25 17.25 14.75 0.92 12.62 24.75 15.59 13.96 0.65
IPW(0.05) Good 1.53 0.13 14.22 14.23 13.40 0.94 12.38 23.46 13.91 13.28 0.68
IPW(0.1) Good 1.53 0.07 12.36 12.36 12.10 0.95 11.91 22.22 12.67 12.56 0.68
IPW(0.15) Good 1.54 0.03 11.55 11.55 11.25 0.95 11.40 21.34 12.08 11.99 0.68
OW Good 1.55 -0.31 10.40 10.40 9.63 0.93 11.64 21.36 11.45 10.86 0.63
MW Good 1.56 -0.46 10.98 10.97 10.28 0.93 11.69 21.94 12.12 11.53 0.66
EW Good 1.54 -0.23 10.60 10.60 9.84 0.94 11.76 21.52 11.54 10.95 0.62
IPW Mod 1.32 6.48 42.94 42.10 31.01 0.81 28.08 49.14 32.18 26.40 0.52
IPW(0.05) Mod 1.36 2.03 20.91 20.73 20.15 0.93 23.84 37.82 19.33 19.71 0.56
IPW(0.1) Mod 1.42 0.72 15.49 15.46 15.56 0.94 21.84 34.56 15.45 15.71 0.49
IPW(0.15) Mod 1.47 0.39 13.58 13.57 13.78 0.95 20.91 33.99 14.32 14.31 0.43
OW Mod 1.44 0.20 11.13 11.13 11.09 0.95 23.65 36.06 12.05 12.11 0.19
MW Mod 1.47 -0.07 11.63 11.64 11.92 0.96 23.76 37.18 12.69 12.97 0.22
EW Mod 1.42 0.47 12.01 12.00 11.76 0.95 23.81 35.93 12.41 12.44 0.22
IPW Poor 1.17 20.80 76.81 72.89 48.34 0.70 45.83 78.22 56.97 42.09 0.52
IPW(0.05) Poor 1.29 1.16 22.52 22.48 22.63 0.93 30.33 45.15 22.30 22.20 0.53
IPW(0.1) Poor 1.39 0.78 16.57 16.54 17.16 0.95 29.24 43.98 16.53 16.79 0.32
IPW(0.15) Poor 1.47 0.10 16.93 16.93 16.17 0.93 27.85 43.92 16.05 15.84 0.25
OW Poor 1.38 -0.14 12.80 12.80 12.80 0.95 32.21 46.38 13.29 13.36 0.08
MW Poor 1.42 -0.24 13.60 13.61 13.75 0.96 31.89 47.49 13.87 14.22 0.10
EW Poor 1.34 0.14 13.99 14.00 13.90 0.94 32.50 45.91 14.11 14.01 0.13
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 -4.17 15.95 14.64 13.85 0.94 -2.31 17.69 17.35 15.56 0.95
IPW(0.05) Good 1.53 -4.34 15.65 14.18 13.58 0.94 -2.66 15.94 15.42 14.70 0.95
IPW(0.1) Good 1.53 -4.66 14.71 12.87 12.62 0.92 -2.97 14.64 13.92 13.76 0.94
IPW(0.15) Good 1.54 -4.60 13.83 11.88 11.59 0.89 -3.12 13.95 13.10 13.06 0.93
OW Good 1.55 -4.27 12.45 10.55 9.83 0.87 -3.06 12.94 12.05 11.35 0.92
MW Good 1.56 -4.10 12.72 10.99 10.30 0.88 -2.93 13.20 12.38 11.65 0.92
EW Good 1.54 -4.31 12.62 10.73 10.04 0.87 -3.01 13.07 12.22 11.55 0.92
IPW Mod 1.32 -10.08 44.15 42.12 33.87 0.93 -1.04 42.46 42.46 33.26 0.90
IPW(0.05) Mod 1.36 -9.77 26.43 22.84 21.90 0.93 -5.54 24.40 23.21 22.82 0.94
IPW(0.1) Mod 1.42 -8.41 19.64 15.63 15.70 0.90 -3.98 18.20 17.32 17.08 0.94
IPW(0.15) Mod 1.47 -7.96 18.28 14.02 13.75 0.86 -3.41 16.30 15.51 15.02 0.93
OW Mod 1.44 -7.34 15.31 11.10 11.16 0.84 -4.18 13.91 12.55 12.55 0.92
MW Mod 1.47 -6.80 15.13 11.35 11.69 0.87 -3.68 13.69 12.58 12.88 0.94
EW Mod 1.42 -8.04 16.75 12.29 12.03 0.84 -4.50 15.14 13.74 13.51 0.92
IPW Poor 1.17 -16.75 92.84 90.79 61.58 0.85 5.54 80.00 79.78 55.34 0.80
IPW(0.05) Poor 1.29 -13.61 29.07 23.13 23.42 0.92 -6.78 25.96 24.44 24.34 0.94
IPW(0.1) Poor 1.39 -11.75 23.72 17.16 17.08 0.85 -4.06 19.46 18.63 18.28 0.94
IPW(0.15) Poor 1.47 -11.40 23.19 16.07 15.59 0.80 -3.27 17.98 17.34 16.87 0.93
OW Poor 1.38 -11.26 20.02 12.65 12.68 0.76 -5.24 15.73 13.99 14.10 0.91
MW Poor 1.42 -10.56 19.92 13.08 13.20 0.79 -4.45 15.62 14.28 14.58 0.93
EW Poor 1.34 -12.73 22.32 14.33 14.23 0.78 -6.19 17.89 15.85 15.76 0.92
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error
in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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Table D.3: Variable omission: homogeneous treatment effect (N = 1000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 0.68 10.39 10.38 9.79 0.93 17.48 20.02 9.75 9.51 0.50
IPW(0.05) Good 1 0.25 8.94 8.94 9.01 0.95 17.38 19.51 8.87 9.08 0.51
IPW(0.1) Good 1 0.09 8.23 8.24 8.23 0.95 17.30 19.31 8.59 8.58 0.47
IPW(0.15) Good 1 0.02 7.81 7.81 7.77 0.95 17.14 19.09 8.41 8.29 0.46
OW Good 1 0.18 6.84 6.84 6.79 0.96 18.18 19.72 7.67 7.59 0.34
MW Good 1 0.27 7.16 7.16 7.19 0.96 19.26 20.86 8.02 8.02 0.34
EW Good 1 0.19 6.96 6.96 6.89 0.95 17.95 19.53 7.70 7.62 0.36
IPW Mod 1 1.33 35.07 35.06 24.03 0.85 28.71 39.25 26.77 19.29 0.50
IPW(0.05) Mod 1 -0.38 14.42 14.42 14.31 0.94 26.93 30.59 14.52 14.14 0.51
IPW(0.1) Mod 1 -0.13 10.23 10.24 10.70 0.96 28.55 30.52 10.79 10.85 0.25
IPW(0.15) Mod 1 0.05 9.55 9.55 9.49 0.96 31.24 32.74 9.82 9.80 0.12
OW Mod 1 -0.27 7.82 7.82 7.76 0.95 33.23 34.30 8.48 8.41 0.03
MW Mod 1 -0.23 8.32 8.32 8.30 0.94 35.86 37.00 9.11 9.00 0.02
EW Mod 1 -0.40 8.36 8.36 8.20 0.95 31.80 32.98 8.74 8.63 0.05
IPW Poor 1 13.31 58.97 57.48 39.46 0.73 40.73 59.27 43.07 32.33 0.54
IPW(0.05) Poor 1 0.70 16.88 16.88 15.70 0.92 36.62 39.96 16.00 15.38 0.35
IPW(0.1) Poor 1 0.64 12.13 12.12 11.70 0.94 42.39 44.00 11.80 11.60 0.06
IPW(0.15) Poor 1 0.65 11.41 11.40 11.03 0.93 46.50 47.83 11.20 10.96 0.01
OW Poor 1 0.30 9.15 9.15 8.82 0.94 46.38 47.34 9.51 9.22 0.00
MW Poor 1 0.34 9.55 9.54 9.44 0.95 49.71 50.71 10.03 9.86 0.00
EW Poor 1 0.37 10.11 10.11 9.60 0.93 43.84 44.99 10.12 9.69 0.01
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 -7.15 12.06 9.71 9.40 0.90 -3.54 11.72 11.18 10.67 0.95
IPW(0.05) Good 1 -7.20 11.93 9.52 9.29 0.89 -4.07 11.03 10.26 10.20 0.93
IPW(0.1) Good 1 -7.54 11.65 8.88 8.80 0.88 -4.39 10.75 9.81 9.68 0.93
IPW(0.15) Good 1 -7.22 10.95 8.24 8.13 0.85 -4.35 10.34 9.38 9.26 0.92
OW Good 1 -6.25 9.42 7.05 6.98 0.84 -3.92 9.10 8.22 8.14 0.92
MW Good 1 -5.51 9.15 7.31 7.27 0.88 -3.42 8.89 8.21 8.24 0.93
EW Good 1 -6.51 9.71 7.20 7.10 0.84 -3.99 9.28 8.39 8.26 0.92
IPW Mod 1 -21.39 37.80 31.18 25.38 0.93 -7.42 33.46 32.64 24.79 0.92
IPW(0.05) Mod 1 -17.46 23.75 16.11 15.57 0.83 -9.96 19.35 16.60 16.33 0.93
IPW(0.1) Mod 1 -12.97 16.73 10.57 10.88 0.80 -7.36 13.86 11.75 12.01 0.92
IPW(0.15) Mod 1 -11.54 15.06 9.69 9.56 0.77 -5.48 11.99 10.67 10.54 0.92
OW Mod 1 -11.31 13.77 7.86 7.86 0.69 -6.74 11.22 8.98 8.92 0.88
MW Mod 1 -9.98 12.87 8.14 8.22 0.76 -5.70 10.75 9.12 9.09 0.90
EW Mod 1 -13.00 15.66 8.73 8.48 0.66 -7.59 12.36 9.75 9.60 0.87
IPW Poor 1 -32.88 74.86 67.28 49.90 0.93 -5.22 62.15 61.96 45.06 0.84
IPW(0.05) Poor 1 -19.76 26.28 17.33 16.38 0.78 -9.45 20.18 17.84 16.89 0.92
IPW(0.1) Poor 1 -16.14 20.17 12.10 11.84 0.71 -6.30 14.05 12.56 12.65 0.93
IPW(0.15) Poor 1 -14.14 17.84 10.89 10.88 0.74 -4.09 12.54 11.86 11.76 0.94
OW Poor 1 -14.47 17.06 9.03 8.81 0.62 -7.19 12.42 10.13 9.84 0.88
MW Poor 1 -12.75 15.78 9.30 9.18 0.71 -5.98 11.78 10.15 10.10 0.91
EW Poor 1 -17.20 19.96 10.12 9.91 0.60 -8.70 14.50 11.61 11.07 0.87
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error
in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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Table D.4: Variable omission: heterogeneous treatment effect (N = 1000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 -0.02 11.12 11.12 10.42 0.95 11.77 20.60 10.14 9.96 0.50
IPW(0.05) Good 1.53 -0.24 9.17 9.17 9.42 0.96 11.65 19.92 8.98 9.39 0.52
IPW(0.1) Good 1.53 -0.33 8.32 8.31 8.46 0.96 11.35 19.39 8.56 8.78 0.49
IPW(0.15) Good 1.54 -0.33 7.88 7.87 7.88 0.94 10.88 18.66 8.15 8.43 0.49
OW Good 1.55 -0.31 6.91 6.90 6.83 0.94 11.45 19.29 7.56 7.68 0.36
MW Good 1.56 -0.31 7.30 7.29 7.19 0.95 11.73 20.01 7.98 8.08 0.39
EW Good 1.54 -0.31 7.01 7.00 6.98 0.94 11.47 19.27 7.60 7.75 0.37
IPW Mod 1.32 1.50 37.34 37.31 25.95 0.82 25.32 43.34 27.51 20.47 0.44
IPW(0.05) Mod 1.36 0.29 14.70 14.70 14.80 0.94 21.73 33.02 14.59 14.50 0.45
IPW(0.1) Mod 1.42 0.34 10.77 10.76 10.88 0.94 20.87 31.51 10.96 11.06 0.24
IPW(0.15) Mod 1.47 0.16 9.37 9.38 9.58 0.96 20.33 31.60 10.02 9.95 0.14
OW Mod 1.44 -0.00 7.63 7.64 7.87 0.95 23.22 34.43 8.44 8.59 0.02
MW Mod 1.47 -0.05 7.96 7.97 8.36 0.96 23.52 35.74 8.94 9.13 0.03
EW Mod 1.42 -0.06 8.30 8.30 8.45 0.95 23.16 33.94 8.74 8.87 0.04
IPW Poor 1.17 12.38 62.87 61.21 41.96 0.73 41.33 64.80 43.14 33.48 0.50
IPW(0.05) Poor 1.29 0.90 16.34 16.30 16.24 0.94 29.58 41.55 16.11 15.81 0.34
IPW(0.1) Poor 1.39 0.62 12.15 12.12 11.92 0.94 28.98 42.11 11.87 11.78 0.09
IPW(0.15) Poor 1.47 0.24 11.60 11.60 11.10 0.94 27.28 41.62 11.36 11.04 0.05
OW Poor 1.38 0.14 9.09 9.09 9.03 0.95 32.07 45.26 9.55 9.43 0.00
MW Poor 1.42 -0.02 9.71 9.71 9.56 0.95 31.73 46.30 10.10 9.97 0.01
EW Poor 1.34 0.29 10.08 10.07 9.96 0.95 32.27 44.56 10.19 9.97 0.01
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.52 -4.48 12.06 9.95 9.69 0.91 -2.60 12.27 11.62 11.06 0.94
IPW(0.05) Good 1.53 -4.65 12.02 9.70 9.55 0.90 -2.93 11.36 10.45 10.43 0.93
IPW(0.1) Good 1.53 -5.13 11.82 8.83 8.97 0.87 -3.21 11.03 9.87 9.76 0.92
IPW(0.15) Good 1.54 -5.02 11.23 8.13 8.20 0.85 -3.11 10.69 9.55 9.25 0.90
OW Good 1.55 -4.33 9.69 7.00 6.98 0.83 -2.89 9.52 8.41 8.06 0.90
MW Good 1.56 -3.99 9.57 7.26 7.25 0.86 -2.60 9.42 8.50 8.17 0.91
EW Good 1.54 -4.43 9.91 7.17 7.14 0.83 -2.92 9.65 8.54 8.22 0.90
IPW Mod 1.32 -13.82 36.12 31.16 26.39 0.94 -4.38 34.45 33.98 26.14 0.91
IPW(0.05) Mod 1.36 -11.65 22.79 16.34 16.01 0.87 -6.49 18.77 16.56 16.60 0.94
IPW(0.1) Mod 1.42 -8.64 16.38 10.91 11.11 0.83 -4.46 13.55 11.99 12.05 0.93
IPW(0.15) Mod 1.47 -8.27 15.68 9.86 9.61 0.76 -3.61 12.00 10.75 10.56 0.92
OW Mod 1.44 -7.65 13.49 7.81 7.93 0.72 -4.27 10.66 8.71 8.90 0.91
MW Mod 1.47 -6.95 12.99 8.02 8.23 0.76 -3.59 10.21 8.74 9.05 0.92
EW Mod 1.42 -8.68 15.00 8.60 8.65 0.71 -4.85 11.76 9.55 9.65 0.90
IPW Poor 1.17 -25.50 79.12 73.32 52.09 0.92 -2.26 63.14 63.11 46.82 0.83
IPW(0.05) Poor 1.29 -14.61 25.65 17.34 16.84 0.82 -6.50 19.08 17.13 17.33 0.94
IPW(0.1) Poor 1.39 -12.49 21.26 12.20 11.99 0.70 -4.19 13.97 12.70 12.74 0.92
IPW(0.15) Poor 1.47 -11.59 20.36 11.19 10.94 0.66 -3.28 13.06 12.15 11.80 0.93
OW Poor 1.38 -11.08 17.78 9.08 8.97 0.61 -5.01 12.02 9.83 9.94 0.90
MW Poor 1.42 -10.12 17.22 9.45 9.26 0.65 -4.25 11.83 10.17 10.16 0.91
EW Poor 1.34 -12.92 20.14 10.20 10.24 0.62 -6.09 13.87 11.20 11.26 0.89
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error
in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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Table D.5: Variable transformation (N = 500).
Homogeneous treatment effect
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 0.05 11.38 11.38 10.83 0.95 0.30 10.80 10.80 10.69 0.95 0.53 12.00 11.99 11.07 0.96
IPW(0.05) Good 1 -0.22 10.36 10.37 10.44 0.96 0.28 10.21 10.21 10.39 0.95 0.66 10.32 10.30 10.30 0.95
IPW(0.1) Good 1 -0.05 9.93 9.93 10.32 0.96 0.40 10.09 10.08 10.27 0.95 0.83 10.08 10.05 10.18 0.95
IPW(0.15) Good 1 0.13 10.19 10.19 10.42 0.94 0.48 10.18 10.17 10.37 0.95 1.03 10.14 10.09 10.27 0.95
OW Good 1 0.03 9.75 9.75 10.02 0.96 0.38 9.66 9.66 9.96 0.95 1.13 9.69 9.63 9.88 0.95
MW Good 1 0.08 9.89 9.89 10.23 0.96 0.33 9.77 9.77 10.15 0.95 1.19 9.79 9.72 10.07 0.95
EW Good 1 0.00 9.78 9.79 10.01 0.95 0.37 9.70 9.70 9.96 0.95 1.06 9.73 9.67 9.88 0.95
IPW Mod 1 1.00 20.34 20.33 14.69 0.89 -0.01 23.43 23.44 17.37 0.91 -1.20 26.10 26.08 19.68 0.91
IPW(0.05) Mod 1 -0.13 14.13 14.14 12.75 0.92 0.55 14.00 13.99 12.82 0.91 0.86 14.02 14.00 12.63 0.91
IPW(0.1) Mod 1 -0.60 13.55 13.55 12.59 0.92 0.24 13.50 13.50 12.61 0.92 1.03 13.22 13.19 12.34 0.93
IPW(0.15) Mod 1 -0.73 14.06 14.05 12.99 0.92 -0.09 13.83 13.84 12.99 0.93 0.79 13.34 13.32 12.59 0.92
OW Mod 1 -0.49 12.59 12.59 11.78 0.93 -0.12 12.37 12.38 11.61 0.93 1.30 12.21 12.15 11.35 0.93
MW Mod 1 -0.63 12.72 12.71 12.08 0.94 -0.31 12.48 12.48 11.91 0.94 1.44 12.37 12.29 11.64 0.94
EW Mod 1 -0.35 12.72 12.72 11.77 0.92 -0.04 12.63 12.63 11.68 0.92 1.09 12.39 12.35 11.42 0.92
IPW Poor 1 2.00 23.37 23.29 16.61 0.88 0.79 30.90 30.91 22.20 0.92 -2.04 37.43 37.39 29.17 0.92
IPW(0.05) Poor 1 0.24 15.43 15.43 14.80 0.94 0.70 16.11 16.10 15.00 0.94 2.10 15.33 15.19 14.49 0.93
IPW(0.1) Poor 1 0.61 15.42 15.41 14.72 0.95 1.42 15.19 15.13 14.71 0.95 2.54 14.60 14.38 14.09 0.94
IPW(0.15) Poor 1 0.55 15.54 15.54 15.41 0.95 1.40 15.35 15.29 15.32 0.95 2.74 14.91 14.66 14.63 0.95
OW Poor 1 0.54 13.39 13.38 13.44 0.96 1.09 13.21 13.18 13.16 0.95 3.25 12.94 12.54 12.62 0.95
MW Poor 1 0.50 13.67 13.67 13.85 0.95 1.04 13.48 13.45 13.59 0.96 3.62 13.28 12.78 13.02 0.95
EW Poor 1 0.55 13.51 13.50 13.43 0.95 1.05 13.43 13.39 13.27 0.95 2.81 13.08 12.78 12.73 0.94
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.46 0.34 12.65 12.65 11.14 0.92 2.15 12.44 12.05 10.97 0.92 2.60 13.13 12.58 11.33 0.92
IPW(0.05) Good 1.47 0.22 11.65 11.65 10.58 0.93 1.41 11.55 11.37 10.58 0.92 1.89 11.71 11.38 10.48 0.92
IPW(0.1) Good 1.50 0.14 11.25 11.25 10.38 0.93 0.67 11.17 11.13 10.37 0.93 1.09 11.19 11.07 10.31 0.93
IPW(0.15) Good 1.53 0.17 11.26 11.26 10.44 0.93 0.36 11.34 11.34 10.43 0.93 0.63 11.19 11.15 10.34 0.93
OW Good 1.52 -0.02 10.92 10.92 10.09 0.93 0.68 10.91 10.86 10.04 0.93 1.23 10.94 10.78 9.97 0.93
MW Good 1.54 -0.16 11.13 11.14 10.27 0.93 0.31 11.06 11.05 10.20 0.93 0.87 11.03 10.96 10.13 0.93
EW Good 1.51 0.03 10.94 10.95 10.09 0.93 0.91 10.96 10.88 10.06 0.93 1.46 11.01 10.79 9.98 0.92
IPW Mod 1.24 2.20 21.04 20.88 15.40 0.87 4.70 23.83 23.11 17.92 0.86 5.54 28.36 27.53 20.55 0.86
IPW(0.05) Mod 1.35 0.66 13.37 13.35 12.82 0.93 2.25 14.12 13.80 13.08 0.93 2.53 13.92 13.50 12.77 0.92
IPW(0.1) Mod 1.42 0.31 13.11 13.11 12.62 0.94 1.08 13.09 13.00 12.74 0.95 1.33 13.02 12.88 12.44 0.95
IPW(0.15) Mod 1.48 -0.01 13.39 13.40 13.03 0.94 0.38 13.68 13.68 13.03 0.94 0.55 13.07 13.05 12.66 0.94
OW Mod 1.43 0.04 11.87 11.88 11.93 0.95 1.32 11.88 11.74 11.78 0.94 2.06 11.92 11.55 11.51 0.94
MW Mod 1.47 -0.11 12.03 12.03 12.21 0.95 0.77 11.93 11.89 12.04 0.95 1.45 11.93 11.75 11.78 0.94
EW Mod 1.40 0.13 11.96 11.97 11.95 0.94 1.71 12.15 11.92 11.86 0.94 2.51 12.20 11.69 11.59 0.93
IPW Poor 1.10 7.24 26.43 25.20 17.20 0.79 9.28 35.54 34.05 23.48 0.83 9.68 37.94 36.43 28.25 0.81
IPW(0.05) Poor 1.31 1.21 16.36 16.29 15.11 0.92 2.53 16.86 16.54 15.33 0.92 2.58 16.19 15.85 14.76 0.92
IPW(0.1) Poor 1.40 0.65 16.44 16.42 15.05 0.92 0.94 16.26 16.21 14.98 0.93 0.55 15.18 15.17 14.38 0.93
IPW(0.15) Poor 1.47 0.08 16.51 16.51 15.45 0.92 -0.22 16.52 16.53 15.43 0.93 -0.57 15.21 15.20 14.68 0.93
OW Poor 1.38 0.59 14.04 14.02 13.78 0.94 1.76 13.98 13.77 13.49 0.94 2.27 13.37 13.01 12.91 0.94
MW Poor 1.43 0.39 14.26 14.26 14.13 0.94 1.05 14.14 14.07 13.85 0.94 1.37 13.37 13.23 13.28 0.94
EW Poor 1.35 0.78 14.11 14.08 13.82 0.94 2.43 14.29 13.91 13.66 0.94 3.06 13.77 13.15 13.05 0.94
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error in
10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
38
Table D.6: Variable transformation (N = 1000).
Homogeneous treatment effect
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 0.33 8.17 8.17 7.79 0.95 0.46 7.96 7.96 7.78 0.96 0.68 8.41 8.38 7.95 0.96
IPW(0.05) Good 1 0.21 7.42 7.42 7.45 0.95 0.59 7.50 7.48 7.41 0.95 0.99 7.43 7.37 7.35 0.96
IPW(0.1) Good 1 0.25 7.32 7.32 7.33 0.95 0.57 7.33 7.31 7.29 0.95 1.11 7.36 7.28 7.24 0.95
IPW(0.15) Good 1 0.32 7.42 7.42 7.38 0.95 0.54 7.40 7.38 7.34 0.95 1.15 7.48 7.39 7.28 0.95
OW Good 1 0.21 7.15 7.15 7.09 0.95 0.53 7.10 7.08 7.05 0.95 1.29 7.15 7.03 7.00 0.95
MW Good 1 0.17 7.30 7.30 7.20 0.95 0.44 7.22 7.21 7.15 0.95 1.36 7.27 7.14 7.10 0.95
EW Good 1 0.23 7.14 7.14 7.10 0.95 0.54 7.09 7.08 7.06 0.95 1.23 7.14 7.04 7.01 0.95
IPW Mod 1 0.03 15.32 15.33 11.85 0.92 -1.91 21.04 20.97 14.63 0.94 -3.41 28.17 27.98 18.16 0.94
IPW(0.05) Mod 1 0.20 9.34 9.34 9.17 0.94 0.51 9.48 9.47 9.28 0.94 1.25 9.18 9.09 9.02 0.94
IPW(0.1) Mod 1 -0.11 9.13 9.13 8.97 0.94 0.32 9.00 9.00 9.02 0.94 1.28 8.72 8.63 8.76 0.95
IPW(0.15) Mod 1 -0.60 9.23 9.22 9.23 0.95 0.10 9.17 9.17 9.22 0.95 1.27 9.05 8.96 8.92 0.94
OW Mod 1 -0.31 8.43 8.43 8.32 0.95 0.07 8.27 8.28 8.20 0.95 1.59 8.21 8.06 8.01 0.94
MW Mod 1 -0.44 8.64 8.63 8.50 0.95 -0.12 8.49 8.49 8.38 0.95 1.68 8.38 8.21 8.19 0.94
EW Mod 1 -0.25 8.49 8.49 8.36 0.95 0.06 8.36 8.36 8.28 0.94 1.33 8.28 8.18 8.09 0.94
IPW Poor 1 0.19 20.92 20.93 14.00 0.89 -3.31 29.23 29.06 21.53 0.93 -7.12 38.64 38.00 31.89 0.94
IPW(0.05) Poor 1 -0.36 11.19 11.19 10.72 0.94 0.57 11.51 11.50 10.89 0.93 1.73 10.86 10.72 10.42 0.94
IPW(0.1) Poor 1 -0.06 11.21 11.21 10.61 0.94 0.45 11.27 11.26 10.61 0.93 2.00 10.54 10.35 10.10 0.94
IPW(0.15) Poor 1 0.36 11.55 11.55 10.96 0.94 0.43 11.43 11.43 10.90 0.94 2.05 10.70 10.50 10.34 0.94
OW Poor 1 -0.13 9.90 9.90 9.55 0.94 0.31 9.68 9.68 9.35 0.94 2.45 9.52 9.20 8.95 0.94
MW Poor 1 -0.04 10.09 10.09 9.77 0.94 0.32 9.82 9.82 9.59 0.95 2.76 9.84 9.44 9.18 0.94
EW Poor 1 -0.25 10.03 10.03 9.60 0.94 0.12 9.87 9.87 9.50 0.94 1.88 9.56 9.38 9.10 0.94
Heterogeneous treatment effect
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.46 0.32 8.60 8.59 8.01 0.94 2.16 8.82 8.24 7.85 0.91 2.73 9.68 8.83 8.07 0.90
IPW(0.05) Good 1.47 0.32 7.96 7.95 7.52 0.93 1.47 8.08 7.78 7.51 0.93 1.97 8.23 7.71 7.43 0.92
IPW(0.1) Good 1.50 0.21 7.74 7.73 7.38 0.94 0.81 7.74 7.65 7.36 0.93 1.19 7.81 7.61 7.31 0.93
IPW(0.15) Good 1.53 0.23 7.73 7.72 7.41 0.94 0.34 7.57 7.56 7.40 0.95 0.75 7.66 7.58 7.33 0.94
OW Good 1.52 0.15 7.39 7.39 7.13 0.94 0.84 7.42 7.31 7.10 0.94 1.37 7.56 7.27 7.05 0.93
MW Good 1.54 0.08 7.49 7.50 7.23 0.94 0.54 7.46 7.42 7.19 0.94 1.06 7.56 7.39 7.14 0.93
EW Good 1.51 0.18 7.42 7.41 7.14 0.94 1.04 7.50 7.33 7.12 0.94 1.58 7.68 7.30 7.07 0.93
IPW Mod 1.24 1.15 17.47 17.42 12.64 0.88 3.79 20.46 19.92 15.13 0.86 4.59 28.18 27.61 18.97 0.84
IPW(0.05) Mod 1.35 0.43 9.90 9.89 9.36 0.93 1.98 10.57 10.23 9.52 0.92 2.47 10.37 9.82 9.27 0.91
IPW(0.1) Mod 1.42 0.16 9.49 9.49 9.10 0.95 1.00 9.53 9.42 9.15 0.94 1.14 9.38 9.25 8.92 0.94
IPW(0.15) Mod 1.48 -0.07 9.50 9.50 9.30 0.94 0.17 9.36 9.36 9.30 0.95 0.11 9.15 9.15 9.02 0.95
OW Mod 1.43 -0.02 8.64 8.65 8.47 0.95 1.23 8.72 8.54 8.37 0.94 1.88 8.74 8.32 8.17 0.93
MW Mod 1.47 -0.12 8.75 8.76 8.62 0.95 0.68 8.64 8.58 8.51 0.95 1.25 8.60 8.40 8.32 0.94
EW Mod 1.40 0.04 8.78 8.78 8.54 0.95 1.62 8.98 8.69 8.47 0.94 2.37 9.11 8.49 8.27 0.92
IPW Poor 1.10 4.88 23.28 22.66 14.88 0.78 7.51 30.41 29.27 21.46 0.81 7.18 39.22 38.43 33.71 0.82
IPW(0.05) Poor 1.31 0.64 11.65 11.62 10.87 0.94 2.26 12.36 12.00 11.01 0.92 2.24 11.54 11.16 10.54 0.92
IPW(0.1) Poor 1.40 0.41 10.92 10.91 10.65 0.94 0.71 11.16 11.12 10.70 0.94 0.48 10.32 10.30 10.22 0.95
IPW(0.15) Poor 1.47 0.07 11.56 11.57 11.02 0.95 -0.03 11.21 11.22 10.97 0.94 -0.64 10.57 10.53 10.42 0.94
OW Poor 1.38 0.31 10.00 10.00 9.75 0.94 1.51 10.04 9.82 9.55 0.93 2.03 9.68 9.26 9.15 0.94
MW Poor 1.43 0.20 10.09 10.09 9.95 0.95 0.86 9.96 9.89 9.77 0.94 1.17 9.48 9.34 9.36 0.94
EW Poor 1.35 0.42 10.27 10.26 9.84 0.94 2.09 10.51 10.13 9.71 0.93 2.77 10.24 9.54 9.31 0.93
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error in
10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
Table E.1: Average treatment prevalence for different levels of PS overlap.
Medium prevalence Low prevalence
PS misspecification Good ModeratePoor Good ModeratePoor
Variable omission 47.42% 47.34% 47.12% 27.7% 18.07% 17.99%
Variable transformation 40.76% 37.63% 37.00% 18.51% 12.79% 10.87%
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Figure E.1: Propensity scores (low prevalence of treatment), with good (left), mod-
erate (middle), and poor (right) overlap. Variable omission (top panel) and variable
transformation (bottom panel).
40
Table E.2: Variable omission: homogeneous treatment effect and low prevalence of treat-
ment (N = 2000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 0.40 13.88 13.88 11.47 0.92 18.57 23.29 14.07 10.52 0.48
IPW(0.05) Good 1 0.09 8.85 8.86 8.57 0.94 18.74 20.75 8.91 8.60 0.41
IPW(0.1) Good 1 0.07 7.19 7.20 6.96 0.94 18.48 19.94 7.50 7.38 0.30
IPW(0.15) Good 1 -0.27 6.35 6.35 6.36 0.95 17.43 18.73 6.85 6.87 0.29
OW Good 1 -0.14 5.26 5.26 5.30 0.95 15.83 16.84 5.76 5.86 0.22
MW Good 1 -0.08 5.74 5.74 5.88 0.96 13.21 14.56 6.12 6.28 0.44
EW Good 1 -0.10 5.56 5.56 5.52 0.94 16.64 17.69 6.00 6.05 0.20
IPW Mod 1 8.65 49.49 48.75 34.61 0.77 37.73 56.27 41.76 29.77 0.50
IPW(0.05) Mod 1 0.43 11.49 11.48 11.28 0.95 34.85 36.82 11.91 11.38 0.16
IPW(0.1) Mod 1 0.36 9.38 9.37 8.93 0.94 30.09 31.95 10.73 9.60 0.14
IPW(0.15) Mod 1 0.60 8.86 8.85 8.55 0.94 12.73 17.34 11.78 9.16 0.67
OW Mod 1 0.15 6.95 6.96 6.68 0.94 23.35 24.51 7.48 7.23 0.11
MW Mod 1 0.12 7.55 7.56 7.41 0.95 17.90 19.56 7.89 7.77 0.35
EW Mod 1 0.21 7.83 7.83 7.52 0.94 26.54 27.75 8.10 7.93 0.09
IPW Poor 1 32.37 84.20 77.77 45.69 0.56 53.43 89.20 71.47 43.92 0.47
IPW(0.05) Poor 1 0.37 12.15 12.16 11.98 0.94 45.21 46.83 12.21 12.08 0.06
IPW(0.1) Poor 1 0.22 9.72 9.72 9.86 0.96 32.32 34.62 12.41 10.44 0.17
IPW(0.15) Poor 1 0.37 9.12 9.12 9.34 0.96 12.01 15.80 10.27 9.76 0.76
OW Poor 1 0.14 7.19 7.19 7.33 0.96 28.83 29.81 7.59 7.83 0.04
MW Poor 1 0.16 7.73 7.73 7.92 0.96 22.34 23.72 8.00 8.24 0.22
EW Poor 1 0.11 8.40 8.40 8.35 0.94 33.13 34.24 8.63 8.61 0.03
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1 -1.67 10.16 10.02 9.38 0.93 -0.91 13.60 13.58 11.16 0.94
IPW(0.05) Good 1 -2.81 9.17 8.73 8.47 0.93 -1.75 9.34 9.18 8.78 0.94
IPW(0.1) Good 1 -4.12 8.20 7.09 6.94 0.91 -2.17 7.81 7.51 7.20 0.93
IPW(0.15) Good 1 -4.43 7.75 6.36 6.34 0.89 -2.03 6.94 6.64 6.59 0.94
OW Good 1 -5.54 7.71 5.36 5.41 0.84 -4.03 7.43 6.25 6.27 0.90
MW Good 1 -6.38 8.65 5.84 5.99 0.82 -4.97 8.70 7.14 7.23 0.89
EW Good 1 -4.83 7.42 5.63 5.57 0.86 -3.44 7.16 6.29 6.23 0.91
IPW Mod 1 3.93 38.03 37.85 29.68 0.83 10.70 48.34 47.16 33.86 0.75
IPW(0.05) Mod 1 -4.52 12.58 11.74 10.99 0.92 0.53 11.58 11.57 10.93 0.93
IPW(0.1) Mod 1 -4.92 10.52 9.30 8.91 0.91 -0.60 9.30 9.28 8.82 0.94
IPW(0.15) Mod 1 -5.23 10.32 8.90 8.59 0.90 -0.78 9.04 9.01 8.62 0.95
OW Mod 1 -7.04 9.93 7.00 6.75 0.81 -5.04 9.40 7.94 7.50 0.88
MW Mod 1 -7.87 10.87 7.50 7.44 0.79 -6.60 11.12 8.96 8.58 0.88
EW Mod 1 -6.00 9.92 7.91 7.48 0.86 -3.38 9.06 8.40 7.92 0.91
IPW Poor 1 10.08 71.43 70.75 46.21 0.73 31.84 87.13 81.14 47.29 0.57
IPW(0.05) Poor 1 -
10.09
16.07 12.52 12.59 0.90 -0.15 11.74 11.74 11.81 0.95
IPW(0.1) Poor 1 -8.80 13.27 9.94 10.04 0.88 -1.65 9.75 9.62 9.81 0.95
IPW(0.15) Poor 1 -7.46 11.87 9.25 9.38 0.88 -1.82 9.49 9.32 9.44 0.95
OW Poor 1 -8.17 10.88 7.19 7.33 0.79 -5.44 9.61 7.93 7.97 0.89
MW Poor 1 -7.30 10.58 7.65 7.84 0.85 -6.45 10.75 8.61 8.71 0.88
EW Poor 1 -8.70 12.10 8.42 8.35 0.83 -3.66 9.51 8.78 8.67 0.93
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard
error in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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Table E.3: Variable omission: heterogeneous treatment effect and low prevalence of
treatment (N = 2000).
Propensity score misspecification
None Missing X2
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.38 0.45 15.09 15.08 12.25 0.90 15.69 26.36 15.05 11.29 0.42
IPW(0.05) Good 1.40 0.18 9.11 9.11 9.05 0.95 15.16 23.08 9.21 9.09 0.36
IPW(0.1) Good 1.44 0.11 7.39 7.39 7.22 0.94 13.36 20.69 7.79 7.79 0.31
IPW(0.15) Good 1.48 -0.09 6.70 6.70 6.50 0.94 11.21 18.16 7.28 7.18 0.36
OW Good 1.46 -0.04 5.58 5.59 5.35 0.94 11.24 17.58 6.24 6.05 0.24
MW Good 1.49 -0.01 6.17 6.18 5.89 0.94 8.88 14.82 6.63 6.37 0.45
Entropy Good 1.45 0.00 5.87 5.87 5.64 0.95 12.25 18.84 6.43 6.31 0.20
IPW Mod 1.12 7.87 53.98 53.28 37.52 0.76 39.83 64.88 46.98 32.39 0.48
IPW(0.05) Mod 1.30 0.15 12.39 12.39 12.02 0.94 27.88 38.32 12.51 12.27 0.19
IPW(0.1) Mod 1.42 -0.02 9.49 9.49 9.25 0.94 20.72 31.18 10.61 10.18 0.20
IPW(0.15) Mod 1.49 -0.03 8.76 8.76 8.71 0.95 8.84 16.78 10.39 9.43 0.70
OW Mod 1.38 -0.17 6.71 6.71 6.83 0.95 17.17 24.79 7.37 7.51 0.11
MW Mod 1.43 -0.28 7.16 7.15 7.48 0.96 12.21 19.02 7.59 7.90 0.38
EW Mod 1.34 -0.09 7.89 7.90 7.84 0.95 20.78 29.01 8.44 8.41 0.09
IPW Poor 1.05 33.33 89.26 82.17 49.62 0.59 61.78 99.92 76.09 48.09 0.46
IPW(0.05) Poor 1.33 0.34 13.52 13.52 12.74 0.94 35.45 48.87 13.05 12.85 0.06
IPW(0.1) Poor 1.43 -0.05 10.49 10.49 10.16 0.94 22.37 34.32 12.47 10.90 0.18
IPW(0.15) Poor 1.49 -0.11 9.56 9.56 9.47 0.95 7.66 15.49 10.45 9.92 0.77
OW Poor 1.39 -0.19 7.66 7.66 7.50 0.95 20.86 30.14 8.20 8.09 0.05
MW Poor 1.44 -0.28 8.29 8.28 8.02 0.95 14.81 22.99 8.63 8.39 0.29
EW Poor 1.34 -0.15 8.89 8.89 8.81 0.95 25.68 35.73 9.26 9.16 0.04
Missing X21 Missing X2X4
Weight Overlap True Bias RMSE SD SE CP Bias RMSE SD SE CP
IPW Good 1.38 0.04 10.72 10.73 9.91 0.94 -0.19 14.56 14.56 11.85 0.92
IPW(0.05) Good 1.40 -1.46 9.34 9.12 8.90 0.94 -1.05 9.43 9.32 9.19 0.95
IPW(0.1) Good 1.44 -2.66 8.20 7.25 7.18 0.92 -1.55 7.95 7.64 7.39 0.92
IPW(0.15) Good 1.48 -2.83 7.97 6.77 6.44 0.89 -1.24 7.33 7.10 6.66 0.92
OW Good 1.46 -3.56 7.70 5.68 5.43 0.83 -2.70 7.57 6.46 6.23 0.90
MW Good 1.49 -4.26 8.94 6.29 5.97 0.80 -3.33 8.92 7.41 7.18 0.89
EW Good 1.45 -2.97 7.29 5.89 5.64 0.87 -2.27 7.25 6.47 6.25 0.91
IPW Mod 1.12 5.96 40.88 40.35 32.26 0.80 10.75 53.19 51.83 36.50 0.74
IPW(0.05) Mod 1.30 -2.57 12.35 11.89 11.65 0.94 0.31 12.08 12.08 11.64 0.94
IPW(0.1) Mod 1.42 -3.57 10.68 9.41 9.17 0.90 -0.40 9.28 9.27 9.08 0.95
IPW(0.15) Mod 1.49 -3.82 10.40 8.72 8.68 0.90 -0.71 8.82 8.76 8.73 0.94
OW Mod 1.38 -5.04 9.71 6.79 6.86 0.83 -3.96 9.21 7.42 7.56 0.89
MW Mod 1.43 -5.86 11.15 7.36 7.51 0.81 -5.06 10.98 8.27 8.60 0.87
EW Mod 1.34 -4.18 9.62 7.84 7.76 0.90 -2.74 9.06 8.29 8.17 0.93
IPW Poor 1.05 13.04 75.66 74.46 51.00 0.71 33.92 92.54 85.47 51.41 0.57
IPW(0.05) Poor 1.33 -6.44 16.11 13.65 13.15 0.92 0.01 13.13 13.14 12.47 0.93
IPW(0.1) Poor 1.43 -5.99 13.55 10.51 10.25 0.87 -1.22 10.42 10.28 10.01 0.94
IPW(0.15) Poor 1.49 -5.18 12.24 9.50 9.45 0.87 -1.17 9.86 9.71 9.50 0.94
OW Poor 1.39 -5.69 11.02 7.67 7.47 0.80 -4.12 9.93 8.12 8.05 0.88
MW Poor 1.44 -5.30 11.20 8.21 7.94 0.82 -4.85 11.26 8.84 8.75 0.86
EW Poor 1.34 -6.06 12.02 8.85 8.76 0.86 -2.81 9.82 9.07 9.05 0.95
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard
error in 10−2; CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
42
l lllll ll lllll l l
l l l llll llll
lll l llll lll
l ll llll l
ll l llll
ll lll lll l
l lll
(−192.19, 36.13)IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
(A)
Good Overlap
l ll ll ll ll l l
ll l l lll
lll lll ll ll
ll ll ll l ll
lll ll l
llll ll l
ll ll lll l
(−326.23, 149.17)IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
Moderate Overlap
l l
ll ll
ll lll l
l ll ll
l lll l llll
ll l l lll
lll l l
(−494.83, 220.87)IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
Poor Overlap
ll ll llll l l
l l lllll
lll llll l ll
lll l llll ll l
lll lll ll l
lll llll lll
lll lll l
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
(B)
ll lll l l llll
l ll ll ll
ll ll lll
l lll ll l
ll lll
ll llll l l l
ll lll l ll lll
(−259.49, 105.09)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
l ll l ll
lll l l
l ll ll
l ll l ll l ll l l
l l ll llll l ll
ll l lll l l
(−477.73, 154.95)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
l l ll ll lll ll ll l
ll l lll l ll ll
l llll l
ll llll ll ll l
l l ll
l lllll
l l l l lll
(−204.34, 36.59)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
(C)
l l lll llll ll l
l lll ll lll
ll l ll
ll l ll lll l l l
ll ll lllll
ll lll ll
lllll l ll ll l ll
(−333.2, 156.15)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
l ll ll
lll ll ll l
l ll ll
l llll l ll llll
lllll
lll l l l
(−580.34, 211.85)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
l ll l l llll l
l l l l ll ll l
lll l llll
l l ll lll lll
ll ll ll ll l
lll l
lll lll l
(−241.55, 51.36)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
(D)
l ll ll ll l llll lll ll lll ll lll l
l ll llll
lll llllll
ll l ll l
l lll llll l l
lll l ll ll ll lll l
ll ll l llll
(−303.61, 169.5)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
ll ll ll l lll ll llll l lll l lll l ll ll lll
l l ll
l l l lll
l ll lll l
l lll l ll lll l l
ll l ll l lll l
l llll
(−536.95, 268.36)
IPW
OW
MW
EW
IPW(0.05)
IPW(0.1)
IPW(0.15)
−100 −50 0 50 100
Relative Bias (%)
Figure E.2: Variable Omission: Relative bias (homogeneous treatment effect and low
prevalence of treatment), with N = 2, 000.
Legend: A: Correct PS Model; B: Missing X21 ; C: Missing X2X4; D: Missing X2.
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Figure E.4: Variable Omission: Relative bias (heterogeneous treatment effect and low
prevalence of treatment), with N = 2000.
Legend: A: Correct PS Model; B: Missing X21 ; C: Missing X2X4; D: Missing X2.
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Table E.4: Variable transformation: low prevalence of treatment (N = 2000).
Homogeneous treatment effect
Propensity score misspecification
None Mild Major
Weight Overlap True Bias RMSESD SE CP Bias RMSESD SE CP Bias RMSESD SE CP
IPW Good 1 0.04 8.61 8.61 8.06 0.95 1.13 7.11 7.02 6.82 0.94 1.42 7.02 6.88 6.70 0.94
IPW(0.05) Good 1 0.07 6.80 6.81 6.86 0.95 0.86 6.61 6.56 6.51 0.94 1.42 6.67 6.52 6.48 0.94
IPW(0.1) Good 1 -0.00 6.71 6.72 6.80 0.96 0.55 6.64 6.62 6.60 0.94 1.16 6.70 6.60 6.55 0.94
IPW(0.15) Good 1 -0.03 7.00 7.00 7.20 0.96 0.33 7.06 7.06 7.22 0.96 1.47 7.34 7.19 7.15 0.94
OW Good 1 -0.00 5.99 5.99 6.13 0.96 0.31 5.99 5.99 6.16 0.96 1.08 6.07 5.98 6.12 0.95
MW Good 1 -0.01 6.07 6.08 6.23 0.96 0.11 6.07 6.07 6.24 0.96 0.91 6.14 6.07 6.20 0.95
EW Good 1 -0.01 6.05 6.05 6.17 0.96 0.48 6.04 6.02 6.14 0.95 1.17 6.12 6.01 6.11 0.94
IPW Mod 1 -0.87 20.66 20.65 14.66 0.87 1.61 13.75 13.66 10.26 0.86 1.30 14.29 14.24 10.54 0.88
IPW(0.05) Mod 1 -0.03 9.29 9.30 9.13 0.94 0.79 8.89 8.86 8.56 0.94 2.08 9.06 8.83 8.47 0.93
IPW(0.1) Mod 1 -0.37 9.23 9.23 9.12 0.95 0.04 9.29 9.30 9.01 0.94 1.85 9.20 9.02 8.89 0.93
IPW(0.15) Mod 1 -0.40 9.98 9.97 9.60 0.95 -0.12 10.25 10.25 9.96 0.94 1.78 10.14 9.99 9.81 0.94
OW Mod 1 -0.31 7.90 7.90 7.78 0.95 0.05 7.86 7.87 7.90 0.95 1.52 7.93 7.78 7.77 0.94
MW Mod 1 -0.32 8.04 8.04 7.97 0.95 -0.22 8.00 8.01 7.99 0.95 1.34 8.04 7.93 7.86 0.94
EW Mod 1 -0.35 8.10 8.09 7.89 0.94 0.39 8.02 8.01 7.84 0.94 1.64 8.06 7.90 7.73 0.94
IPW Poor 1 2.01 29.86 29.81 15.98 0.73 4.08 21.91 21.53 12.18 0.75 2.03 25.09 25.02 15.56 0.79
IPW(0.05) Poor 1 0.26 11.50 11.51 10.77 0.93 1.29 11.07 11.00 10.31 0.93 3.00 11.31 10.91 10.09 0.91
IPW(0.1) Poor 1 0.40 11.67 11.67 10.74 0.93 0.88 11.74 11.71 10.76 0.93 2.94 11.92 11.56 10.48 0.90
IPW(0.15) Poor 1 0.30 12.13 12.14 11.27 0.92 0.59 12.65 12.64 11.66 0.92 2.74 12.34 12.04 11.41 0.93
OW Poor 1 0.28 9.68 9.68 9.16 0.93 0.75 9.76 9.73 9.32 0.94 2.66 9.89 9.53 9.05 0.93
MW Poor 1 0.30 9.88 9.88 9.39 0.93 0.51 9.93 9.92 9.42 0.93 2.56 10.02 9.69 9.16 0.93
EW Poor 1 0.27 9.91 9.91 9.30 0.93 1.15 9.99 9.93 9.25 0.93 2.74 10.11 9.73 9.01 0.91
Heterogeneous treatment effect
None Mild Major
Weight Overlap True Bias RMSESD SE CP Bias RMSESD SE CP Bias RMSESD SE CP
IPW Good 1.21 0.59 8.86 8.83 8.24 0.93 4.48 8.94 7.13 6.96 0.86 5.72 9.83 6.99 6.82 0.81
IPW(0.05) Good 1.28 0.36 7.18 7.17 6.91 0.94 1.05 6.96 6.83 6.60 0.93 2.00 7.17 6.70 6.57 0.93
IPW(0.1) Good 1.36 0.15 6.85 6.85 6.87 0.94 0.37 6.78 6.76 6.68 0.94 1.25 6.95 6.74 6.65 0.94
IPW(0.15) Good 1.44 0.03 7.25 7.25 7.25 0.95 1.06 7.43 7.28 7.27 0.95 1.53 7.54 7.22 7.23 0.93
OW Good 1.36 0.13 6.09 6.09 6.22 0.96 0.33 6.08 6.07 6.25 0.95 1.20 6.23 6.02 6.23 0.94
MW Good 1.39 0.03 6.17 6.17 6.33 0.95 -0.25 6.15 6.15 6.34 0.95 0.44 6.09 6.06 6.31 0.95
EW Good 1.33 0.19 6.14 6.14 6.25 0.95 0.88 6.21 6.10 6.23 0.94 1.81 6.51 6.05 6.21 0.94
IPW Mod 1.01 2.62 22.28 22.14 15.49 0.82 11.41 18.01 13.85 10.65 0.67 13.08 19.81 14.78 11.05 0.64
IPW(0.05) Mod 1.26 0.05 9.61 9.61 9.29 0.95 1.58 9.50 9.29 8.78 0.93 3.40 10.23 9.30 8.69 0.90
IPW(0.1) Mod 1.38 -0.17 9.42 9.42 9.21 0.94 1.85 9.62 9.28 9.14 0.94 3.35 10.18 9.08 9.05 0.92
IPW(0.15) Mod 1.46 -0.40 9.43 9.42 9.68 0.96 2.08 10.25 9.79 10.03 0.94 3.37 11.01 9.85 9.93 0.92
OW Mod 1.32 -0.21 7.79 7.79 7.97 0.96 0.16 7.85 7.85 8.10 0.96 1.95 8.19 7.78 8.00 0.95
MW Mod 1.37 -0.31 7.92 7.91 8.13 0.96 -0.53 7.96 7.93 8.17 0.96 0.99 8.03 7.92 8.07 0.96
EW Mod 1.27 -0.15 8.00 8.01 8.10 0.95 0.98 8.10 8.01 8.06 0.95 2.85 8.66 7.87 7.97 0.93
IPW Poor 0.92 8.96 30.35 29.23 16.68 0.68 18.06 27.31 21.70 12.51 0.57 19.01 29.36 23.61 14.77 0.56
IPW(0.05) Poor 1.27 0.21 11.72 11.72 10.99 0.93 2.41 11.90 11.51 10.54 0.92 4.77 12.92 11.42 10.34 0.88
IPW(0.1) Poor 1.39 -0.08 11.41 11.42 10.80 0.93 2.57 11.82 11.28 10.85 0.93 4.73 13.12 11.36 10.65 0.90
IPW(0.15) Poor 1.47 -0.29 11.63 11.63 11.29 0.94 2.05 12.74 12.39 11.70 0.92 3.91 13.53 12.26 11.47 0.91
OW Poor 1.32 -0.17 9.59 9.59 9.38 0.94 0.65 9.72 9.69 9.56 0.94 2.97 10.31 9.54 9.32 0.93
MW Poor 1.38 -0.30 9.77 9.77 9.58 0.94 -0.01 9.84 9.84 9.62 0.94 1.92 10.02 9.66 9.38 0.94
EW Poor 1.27 -0.06 9.79 9.79 9.56 0.94 1.48 10.03 9.86 9.51 0.93 3.91 10.89 9.70 9.31 0.91
Mod: Moderate; IPW(α): trimmed IPW with Iα(x) = 1({α ≤ e(x) ≤ 1− α}), for α = 0.05, 0.10, and 0.15.
Bias: relative bias in percentage; RMSE: root mean-squared error in 10−2; SD: empirical standard deviation in 10−2; SE: average estimated standard error in 10−2;
CP: coverage probability of 95% confidence interval. The results are based on 1000 simulated data sets.
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Figure E.6: Variable Transformation: Rel. bias (homogeneous trt. effect, low prevalence,
and N = 2000).
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Figure E.7: Variable Transformation: Rel. bias (heterogeneous trt. effect, low preva-
lence, and N = 2000).
Legend: A: Correct PS Model; B: Mild PS Model Misspecification; C: Major PS Model Mis-
specification.
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